WO2011070613A1 - Composition for contact lenses and method for suppressing negative interaction using same - Google Patents
Composition for contact lenses and method for suppressing negative interaction using same Download PDFInfo
- Publication number
- WO2011070613A1 WO2011070613A1 PCT/JP2009/006704 JP2009006704W WO2011070613A1 WO 2011070613 A1 WO2011070613 A1 WO 2011070613A1 JP 2009006704 W JP2009006704 W JP 2009006704W WO 2011070613 A1 WO2011070613 A1 WO 2011070613A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- contact lens
- solution
- liquid
- composition
- contact
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 180
- 230000003993 interaction Effects 0.000 title claims abstract description 116
- 238000000034 method Methods 0.000 title claims description 18
- 239000007788 liquid Substances 0.000 claims abstract description 206
- 239000002244 precipitate Substances 0.000 claims abstract description 55
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 46
- 238000001879 gelation Methods 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- -1 polyol compound Chemical class 0.000 claims description 131
- 239000000243 solution Substances 0.000 claims description 96
- 229920005862 polyol Polymers 0.000 claims description 91
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 64
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 61
- 238000002156 mixing Methods 0.000 claims description 31
- 238000004140 cleaning Methods 0.000 claims description 29
- 239000003795 chemical substances by application Substances 0.000 claims description 24
- 238000004806 packaging method and process Methods 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 20
- 230000009467 reduction Effects 0.000 claims description 20
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 19
- 229930195725 Mannitol Natural products 0.000 claims description 19
- 239000000594 mannitol Substances 0.000 claims description 19
- 235000010355 mannitol Nutrition 0.000 claims description 19
- 239000003889 eye drop Substances 0.000 claims description 17
- 230000000844 anti-bacterial effect Effects 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 239000004386 Erythritol Substances 0.000 claims description 11
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 11
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 11
- 235000019414 erythritol Nutrition 0.000 claims description 11
- 229940009714 erythritol Drugs 0.000 claims description 11
- 239000003755 preservative agent Substances 0.000 claims description 8
- 239000012487 rinsing solution Substances 0.000 claims description 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 4
- 239000000845 maltitol Substances 0.000 claims description 4
- 235000010449 maltitol Nutrition 0.000 claims description 4
- 229940035436 maltitol Drugs 0.000 claims description 4
- 230000000887 hydrating effect Effects 0.000 claims description 3
- 230000007423 decrease Effects 0.000 abstract description 26
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 63
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 40
- 239000004327 boric acid Substances 0.000 description 40
- 238000001556 precipitation Methods 0.000 description 34
- 230000000052 comparative effect Effects 0.000 description 19
- 235000002639 sodium chloride Nutrition 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- 229940012356 eye drops Drugs 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 230000036571 hydration Effects 0.000 description 9
- 238000006703 hydration reaction Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000002997 ophthalmic solution Substances 0.000 description 8
- 229940054534 ophthalmic solution Drugs 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000003899 bactericide agent Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920002413 Polyhexanide Polymers 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000006172 buffering agent Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
- 229960001484 edetic acid Drugs 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 3
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960002684 aminocaproic acid Drugs 0.000 description 3
- 239000000607 artificial tear Substances 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007951 isotonicity adjuster Substances 0.000 description 3
- 239000004328 sodium tetraborate Substances 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 239000002352 surface water Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010015946 Eye irritation Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- DJDFFEBSKJCGHC-UHFFFAOYSA-N Naphazoline Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 DJDFFEBSKJCGHC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 150000001483 arginine derivatives Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229960004926 chlorobutanol Drugs 0.000 description 2
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000882 contact lens solution Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 229960003072 epinephrine hydrochloride Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 231100000013 eye irritation Toxicity 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229940093158 polyhexanide Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000003761 preservation solution Substances 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940037001 sodium edetate Drugs 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- XUBOMFCQGDBHNK-JTQLQIEISA-N (S)-gatifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=CN2C3CC3)=O)=C2C(OC)=C1N1CCN[C@@H](C)C1 XUBOMFCQGDBHNK-JTQLQIEISA-N 0.000 description 1
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
- FWLKKPKZQYVAFR-LVEZLNDCSA-N (e)-but-2-enedioic acid;1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.N=1C2=CC=CC=C2N(CCOCC)C=1N1CCCN(C)CC1 FWLKKPKZQYVAFR-LVEZLNDCSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- WUWFMDMBOJLQIV-UHFFFAOYSA-N 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid Chemical compound C1C(N)CCN1C(C(=C1)F)=NC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C=C1F WUWFMDMBOJLQIV-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- OMCPLEZZPVJJIS-UHFFFAOYSA-N Hypadil (TN) Chemical compound C1C(O[N+]([O-])=O)COC2=C1C=CC=C2OCC(O)CNC(C)C OMCPLEZZPVJJIS-UHFFFAOYSA-N 0.000 description 1
- ZJVFLBOZORBYFE-UHFFFAOYSA-N Ibudilast Chemical compound C1=CC=CC2=C(C(=O)C(C)C)C(C(C)C)=NN21 ZJVFLBOZORBYFE-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- HVRLZEKDTUEKQH-NOILCQHBSA-N Olopatadine hydrochloride Chemical compound Cl.C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 HVRLZEKDTUEKQH-NOILCQHBSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229950001122 acitazanolast Drugs 0.000 description 1
- VWQZJJZGISNFOE-UHFFFAOYSA-N acitazanolast Chemical compound OC(=O)C(=O)NC1=CC=CC(C2=NNN=N2)=C1 VWQZJJZGISNFOE-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960003731 amlexanox Drugs 0.000 description 1
- SGRYPYWGNKJSDL-UHFFFAOYSA-N amlexanox Chemical compound NC1=C(C(O)=O)C=C2C(=O)C3=CC(C(C)C)=CC=C3OC2=N1 SGRYPYWGNKJSDL-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- OJVABJMSSDUECT-UHFFFAOYSA-L berberin sulfate Chemical compound [O-]S([O-])(=O)=O.C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2.C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 OJVABJMSSDUECT-UHFFFAOYSA-L 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229960004324 betaxolol Drugs 0.000 description 1
- CHDPSNLJFOQTRK-UHFFFAOYSA-N betaxolol hydrochloride Chemical compound [Cl-].C1=CC(OCC(O)C[NH2+]C(C)C)=CC=C1CCOCC1CC1 CHDPSNLJFOQTRK-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960001222 carteolol Drugs 0.000 description 1
- LWAFSWPYPHEXKX-UHFFFAOYSA-N carteolol Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(O)CNC(C)(C)C LWAFSWPYPHEXKX-UHFFFAOYSA-N 0.000 description 1
- HJJDBAOLQAWBMH-YCRCPZNHSA-N cefmenoxime Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NN=NN1C HJJDBAOLQAWBMH-YCRCPZNHSA-N 0.000 description 1
- 229960003791 cefmenoxime Drugs 0.000 description 1
- 150000001782 cephems Chemical class 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229940099041 chlorine dioxide Drugs 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 1
- 229960003807 dibekacin Drugs 0.000 description 1
- PIZLBWGMERQCOC-UHFFFAOYSA-N dibenzyl carbonate Chemical compound C=1C=CC=CC=1COC(=O)OCC1=CC=CC=C1 PIZLBWGMERQCOC-UHFFFAOYSA-N 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- OCUJLLGVOUDECM-UHFFFAOYSA-N dipivefrin Chemical compound CNCC(O)C1=CC=C(OC(=O)C(C)(C)C)C(OC(=O)C(C)(C)C)=C1 OCUJLLGVOUDECM-UHFFFAOYSA-N 0.000 description 1
- 229960000966 dipivefrine Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- IKALZAKZWHFNIC-JIZZDEOASA-L dipotassium;(2s)-2-aminobutanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O IKALZAKZWHFNIC-JIZZDEOASA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229960001971 ebastine Drugs 0.000 description 1
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 1
- 229960000325 emedastine Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- FAOZLTXFLGPHNG-KNAQIMQKSA-N fluorometholone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@]2(F)[C@@H](O)C[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FAOZLTXFLGPHNG-KNAQIMQKSA-N 0.000 description 1
- 229960001048 fluorometholone Drugs 0.000 description 1
- 229960003923 gatifloxacin Drugs 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 229960002491 ibudilast Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- YNQQEYBLVYAWNX-WLHGVMLRSA-N ketotifen fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 YNQQEYBLVYAWNX-WLHGVMLRSA-N 0.000 description 1
- 229960003630 ketotifen fumarate Drugs 0.000 description 1
- 229960001828 levocabastine hydrochloride Drugs 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229960003702 moxifloxacin Drugs 0.000 description 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229960004760 naphazoline hydrochloride Drugs 0.000 description 1
- 229960004186 naphazoline nitrate Drugs 0.000 description 1
- OSZNNLWOYWAHSS-UHFFFAOYSA-M neostigmine methyl sulfate Chemical compound COS([O-])(=O)=O.CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 OSZNNLWOYWAHSS-UHFFFAOYSA-M 0.000 description 1
- 229960002253 neostigmine methylsulfate Drugs 0.000 description 1
- 229950000754 nipradilol Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229960003139 olopatadine hydrochloride Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 229960004811 pemirolast potassium Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 description 1
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- NMMVKSMGBDRONO-UHFFFAOYSA-N potassium;9-methyl-3-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one Chemical compound [K+].CC1=CC=CN(C2=O)C1=NC=C2C1=NN=N[N-]1 NMMVKSMGBDRONO-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940072132 quinolone antibacterials Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- XWGJFPHUCFXLBL-UHFFFAOYSA-M rongalite Chemical compound [Na+].OCS([O-])=O XWGJFPHUCFXLBL-UHFFFAOYSA-M 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229920005613 synthetic organic polymer Polymers 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940021790 tetrahydrozoline hydrochloride Drugs 0.000 description 1
- BJORNXNYWNIWEY-UHFFFAOYSA-N tetrahydrozoline hydrochloride Chemical compound Cl.N1CCN=C1C1C2=CC=CC=C2CCC1 BJORNXNYWNIWEY-UHFFFAOYSA-N 0.000 description 1
- 229960004605 timolol Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229950008187 tosufloxacin Drugs 0.000 description 1
- 229960005342 tranilast Drugs 0.000 description 1
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/14—Boron; Compounds thereof
Definitions
- the present invention relates to a composition for contact lenses and a method for suppressing negative interaction using the composition.
- the contact lens is in contact with various liquids from the time it is manufactured until it is used by the user and during the period of use by the user. Specifically, for example, from manufacturing to use by the user, it is stored in a package soaked in the packaging solution, and when used by the user, it comes into contact with contact lens mounting solution or eye drops. It becomes. Furthermore, when the user cleans the worn contact lens, the user comes into contact with the contact lens multipurpose liquid, sterilizing liquid, cleaning liquid, rinsing liquid, and the like, and then stored in a liquid such as a storage liquid. As described above, various liquids come into contact with the contact lens on a daily basis, and in the process, various liquids are often mixed and contacted with the contact lens.
- a contact lens composition for reducing the feeling of foreign matter and dryness when wearing a contact lens As a contact lens composition for reducing the feeling of foreign matter and dryness when wearing a contact lens, cited reference 1 (Japanese Patent Application Laid-Open No. 2004-77953) and cited reference 2 (Japanese Patent Application Laid-Open No. 2006-2007). No. 39529), cited reference 3 (Japanese Patent Laid-Open No. 2003-107416), and the like are considered. Moreover, the composition for contact lenses described in the cited reference 4 (patent 4267673) etc. are also devised as what stabilized viscosity more than these compositions for contact lenses.
- a contact lens composition such as a mounting liquid used in contact with a contact lens is mixed with various liquids that come into contact with other contact lenses in actual use.
- various liquids already in contact with the contact lens for example, multipurpose liquids for contact lenses, packaging solutions, protein washing / removal
- the agent, the preserving liquid, the cleaning liquid, the rinsing liquid, and the mounting liquid come into contact with each other and are mixed with each other.
- the wearer's tear fluid, eye drops, eye wash, and the like are brought into contact and mixed.
- two or more eye drops may be used in combination, or a protein washing / removing agent may be added to the preservation solution.
- the present invention has been made in the background as described above, and the problem to be solved is that the first liquid that comes into contact with the contact lens and the composition for contact lens are mixed and contacted.
- An object of the present invention is to provide a novel composition for contact lenses that can suppress the occurrence of negative interactions caused by the above.
- an object of the present invention is to provide a novel method for suppressing such negative interaction.
- the first aspect of the present invention relating to a contact lens composition is a multipurpose solution for contact lenses, a bactericidal solution, a cleaning solution, a protein cleaning / removing agent, a preserving solution, a rinsing solution, an ophthalmic solution, an eyewash solution, a mounting solution, a packaging.
- a contact lens composition that is mixedly contacted with a first liquid that comes into contact with a contact lens selected from at least one of a solution, a hydration treatment liquid, and a tear fluid.
- the composition for contact lenses according to the present invention for example, even if the contact lens composition such as a mounting liquid or eye drops is mixed and contacted with the first liquid such as the multipurpose liquid for contact lenses, Contact lenses associated with such negative interactions can be suppressed by suppressing the occurrence of negative interactions, that is, the formation of precipitates, the formation of precipitates, gelation, reduction in viscosity, reduction in water wettability of contact lens surfaces, etc. It is possible to prevent the appearance of foreign matter and dryness during wearing, and it is possible to prevent the wearing feeling from being lowered. In addition, by suppressing the occurrence of such negative interactions, the physical properties of the composition for contact lenses and the solution characteristics of the first liquid are prevented from being deteriorated, and the respective desired effects are exhibited well. Can do. Moreover, according to the present invention, in addition to the above-described phenomenon such as the formation of precipitates, it is possible to suppress negative interactions such as a decrease in bactericidal efficacy and a decrease in drug efficacy.
- a second aspect of the present invention relating to a contact lens composition is characterized in that the contact lens composition according to the first aspect includes a low-molecular polyol compound.
- the water wettability of the contact lens surface can be improved by blending the low molecular polyol compound according to this embodiment. Thereby, a dry feeling at the time of wearing a contact lens can be prevented, and the wearing feeling can be further improved.
- the contact lens composition according to the second aspect wherein the low-molecular polyol compound is glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, multi It contains at least one selected from Toll, Mannitol, and Sorbitol.
- the low-molecular polyol compound is glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, multi It contains at least one selected from Toll, Mannitol, and Sorbitol.
- the negative interaction caused by the mixed contact between the contact lens composition and the first liquid can be particularly suitably suppressed. That is, by adopting the above-mentioned sugar and / or sugar alcohol as the low molecular weight polyol compound, negative effects caused between the components of the composition for contact lenses and the components such as boric acid contained in the first liquid. Can be particularly preferably inhibited, and as a result, it is possible to effectively prevent a decrease in wearing feeling due to the occurrence of precipitation or the like.
- a fourth aspect of the present invention relating to a contact lens composition is characterized in that the contact lens composition according to any one of the first to third aspects includes a polymer polyol compound.
- the viscosity of the contact lens composition can be effectively improved, and the wearing feeling of the contact lens can be further improved. That is, in the conventional contact lens composition, the polymer polyol compound has been blended for the purpose of increasing the viscosity and improving the wearing feeling, but the polymer polyol compound is used as the first liquid. When mixed and contacted, negative interactions such as the formation of precipitates and a decrease in viscosity occur between the components of the first liquid and the polymer polyol compound, and the feeling of wearing may decrease on the contrary. .
- the negative interaction with the first liquid can be suppressed, so that a decrease in viscosity and the like can be prevented, and the wearing feeling of the contact lens can be prevented. Can be improved effectively.
- the wettability of the contact lens surface is particularly preferably improved, so that the wearing feeling of the contact lens can be further improved.
- a fifth aspect of the present invention relating to a contact lens composition is the contact lens composition according to the fourth aspect, wherein the polymer polyol compound has a kinematic viscosity of 30 mm 2 / s or less in a 4% by weight aqueous solution. It is characterized by being a certain polyvinyl alcohol.
- the first aspect of the present invention relating to a method for suppressing negative interactions is a multipurpose solution for contact lenses, a bactericidal solution, a washing solution, a protein washing / removing agent, a preserving solution, a rinsing solution, an ophthalmic solution, an eyewash solution, and an attachment
- a negative liquid generated by mixing and contacting a contact lens composition with a first liquid that contacts a contact lens selected from at least one of a liquid, a packaging solution, a hydration solution, and a tear fluid
- a method for suppressing interaction wherein the contact lens composition according to any one of claims 1 to 5 is used as the contact lens composition, and mixed contact with the first liquid is performed.
- the negative interaction is characterized by suppressing at least one of precipitate formation, precipitate formation, gelation, viscosity reduction, and contact lens surface water wettability reduction.
- the contact lens composition according to any one of the first to fifth aspects of the present invention related to the contact lens composition described above a first contact with the contact lens is achieved. Negative interaction due to mixed contact between the liquid and the contact lens composition can be suppressed, and deterioration of wearing feeling, deterioration of liquidity, and the like can be prevented.
- the second aspect of the present invention relating to a method for suppressing negative interaction is a multipurpose solution for contact lenses, a bactericidal solution, a washing solution, a protein washing / removing agent, a preservation solution, a rinsing solution, an ophthalmic solution, an eyewash solution, and a wearing
- a negative liquid generated by mixing and contacting a contact lens composition with a first liquid that contacts a contact lens selected from at least one of a liquid, a packaging solution, a hydration solution, and a tear fluid
- the contact lens composition is at least one selected from low molecular polyol compounds consisting of glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, maltitol, mannitol, sorbitol.
- the negative contact due to the mixed contact with the first liquid.
- composition for contact lenses containing the low molecular polyol compound by using the composition for contact lenses containing the low molecular polyol compound, negative interaction due to the mixed contact between the first liquid contacting the contact lenses and the composition for contact lenses is suppressed. be able to.
- the present invention even if the first liquid that contacts the contact lens and the contact lens composition are mixed and contacted, the formation of precipitates, the formation of precipitates, gelation, the decrease in viscosity, the contact lens surface Negative interactions such as reduced water wettability are suppressed. Thereby, it is possible to prevent a decrease in wearing feeling of the contact lens due to the negative interaction.
- the contact lens composition as one embodiment of the present invention relating to a contact lens composition is a multipurpose solution for contact lenses, a bactericidal solution, a cleaning solution, a protein cleaning / removing agent, a storage solution, a rinsing solution, an ophthalmic solution, an eyewash solution, It is used after being mixed and contacted with a first liquid that comes into contact with a contact lens selected from at least one of a mounting liquid, a packaging solution, a hydration treatment liquid, and a tear liquid. And the composition for contact lenses according to the present embodiment also reduces the formation of precipitates, the formation of precipitates, gelation, the decrease in viscosity, and the water wettability of the contact lens surface by mixing contact with the first liquid.
- the first liquid referred to in the present embodiment the first liquid
- the negative interaction that occurs in mixed contact with a conventional contact lens composition will be described.
- contact lens mounting solutions have been considered as contact lens mounting solutions, eye drops, and the like.
- a contact lens composition such as a mounting solution
- the mounting liquid is often used by being dropped onto a contact lens immediately before wearing, but the storage liquid or cleaning liquid adhered to the contact lens immediately before wearing when it is taken out from a storage container or the like. Or a mixture thereof is in contact.
- the mounting liquid is dropped onto such a contact lens, the mounting liquid comes into contact with the storage liquid, the cleaning liquid, and the like on the lens surface and is mixed.
- the components included in the contact lens composition and the components included in the first liquid May cause undesired phenomena such as formation of precipitates, formation of precipitates, gelation, decrease in viscosity, and reduction in water wettability of contact lens surfaces.
- these unfavorable phenomena such as the formation of precipitates, the formation of precipitates, gelation, reduction in viscosity, and reduction in water wettability of the contact lens surface are collectively referred to as negative interactions. If such a negative interaction occurs, there is a risk that an unpleasant phenomenon will be caused to the user, such as a feeling of foreign matter or dryness when the contact lens is worn, or a blurred field of view.
- the contact lens composition as a mounting liquid has an effect such as improvement of water wettability that is aimed at, or the first liquid has a buffering action. There is a possibility that the various effects of the decrease.
- composition for contact lenses according to the present embodiment can suitably suppress the negative interaction caused by the mixed contact between the first liquid and the composition for contact lenses.
- this embodiment is explained in full detail.
- a contact lens in this embodiment a hard contact lens, an oxygen permeable hard contact lens, a soft contact lens, a silicone hydrogel soft contact lens, a hybrid contact lens (a combination of an oxygen permeable hard contact lens and a soft contact lens)
- Well-known contact lenses such as contact lenses
- orthokeratology lenses fashionable color contact lenses, and the like are used without particular limitation.
- the usage form of the contact lens is not particularly limited. That is, it may be a disposable contact lens that is used only for a short period such as one day or one week to several months, or a normal contact lens that is used for a longer period.
- the contact lens composition When the contact lens composition is mixed and contacted with the first liquid described later, the contact lens composition has at least one negative effect of precipitation formation, precipitate formation, gelation, viscosity reduction, and contact lens surface water wettability reduction. It has a composition that can suppress the interaction.
- the specific composition of the contact lens composition is not particularly limited as long as negative interaction can be suppressed, but preferably, for example, a low molecular polyol compound is blended in the contact lens composition.
- a low molecular polyol compound is blended in the contact lens composition.
- the negative interaction with the first liquid can be particularly suitably suppressed.
- such a low molecular polyol compound suppresses the negative interaction by mixing boric acid in at least one of the contact lens composition and the first liquid and polyvinyl alcohol in the other. In particular, it is particularly effective.
- the negative interaction suppression effect by the low-molecular polyol compound works effectively even for negative interactions caused by causes other than mixing of boric acid and polyvinyl alcohol.
- the wettability of the contact lens is also improved, so that the wearing feeling of the contact lens is also improved.
- the low molecular polyol compound in particular, a compound selected from at least one of glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, maltitol, mannitol, and sorbitol is desirably employed.
- a compound selected from at least one of glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, maltitol, mannitol, and sorbitol is desirably employed.
- negative interactions can be particularly effectively suppressed while preventing eye irritation and effects on physical properties of contact lenses.
- a low molecular polyol compound only 1 type of the above-mentioned substance may be employ
- glucose, trehalose, erythritol, mannitol, and sorbitol are preferably employed, more preferably erythritol and mannitol are employed, and most preferably mannitol is employed.
- Such a low-molecular polyol compound is desirably blended at a concentration of 0.1 to 10% by weight, and more desirably at a concentration of 0.5 to 5% by weight. If the concentration is within such a range, the negative interaction can be suppressed particularly effectively. That is, even if the concentration is increased to more than 10% by weight, the negative interaction suppressing effect becomes flat and waste may occur. Furthermore, when the osmotic pressure increases, there may be a case where the contact lens specification changes or eye irritation occurs. On the other hand, when the concentration is less than 0.1% by weight, there is a possibility that the effect of suppressing the negative interaction cannot be sufficiently obtained.
- the concentration ratio of the high molecular polyol compound to the low molecular polyol compound is 1: 1 to 1:10 ( High molecular polyol compound: low molecular polyol compound) is preferable.
- High molecular polyol compound: low molecular polyol compound By blending the low-molecular polyol compound at such a concentration ratio, a more desirable negative interaction suppression effect can be obtained.
- the causes of various negative interactions caused by the mixed contact between the conventional contact lens composition and the first liquid, and the mechanism by which such negative interactions are suppressed by the blending of the low molecular polyol compound are as follows. Although not yet clear, the following hypothesis is considered as one guess. For example, in the mixed contact of the contact lens composition containing polyvinyl alcohol and the first liquid containing boric acid, boric acid contained in the first liquid and the like, polyvinyl alcohol contained in the contact lens composition, etc. One of the causes is considered to form a network due to hydrogen bonding or the like during mixing.
- a low molecular polyol compound such as mannitol is blended in the contact lens composition, so that the hydroxyl group (—OH) of the low molecular polyol compound is involved in the formation of a network by hydrogen bonding. Therefore, it is speculated that the formation can be inhibited, and as a result, negative interactions such as precipitation, cloudiness, and gelation can be suppressed.
- the low-molecular polyol compound such as mannitol described above is blended particularly when boric acid is blended in one of the contact lens composition and the first liquid and polyvinyl alcohol is blended in the other. In addition, it is possible to particularly effectively prevent the negative interaction due to the mixture of boric acid and polyvinyl alcohol.
- the present embodiment is particularly preferably applied to a contact lens composition containing a polymer polyol compound such as polyvinyl alcohol. That is, the composition for contact lenses is often blended with a polymer polyol compound such as polyvinyl alcohol as a thickener for improving the viscosity of the composition for contact lenses.
- a polymer polyol compound such as polyvinyl alcohol as a thickener for improving the viscosity of the composition for contact lenses.
- a polymer polyol compound when such a polymer polyol compound is mixed with a first liquid containing boric acid or the like, negative interactions such as precipitation, white turbidity, and gelation occur. Wearing feeling may be greatly reduced.
- the first liquid contains boric acid
- a negative interaction such as formation of a precipitate occurs.
- the contact lens composition containing a polymer polyol compound such as polyvinyl alcohol and the first liquid containing boric acid are mixed and contacted, the contact lens composition has mannitol or the like. Negative interaction can be suppressed, for example, by blending the low molecular polyol compound. As a result, the thickening action of the polymer polyol compound can be sufficiently exerted.
- the wettability of the contact lens is greatly enhanced by the synergistic effect. That is, the low-molecular polyol compound has an effect of improving the wettability to some extent in addition to the action of suppressing the negative interaction, but the wettability is further increased by blending it with the high-molecular polyol compound. It is. Therefore, by combining a high-molecular polyol compound and a low-molecular polyol compound in combination, the wettability of the contact lens is greatly improved and the formation of gelation and precipitation due to the interaction with the first liquid is suppressed. This can advantageously improve the wearing feeling of the contact lens. Therefore, it is desirable that the composition for contact lenses according to the present embodiment contains a polymer polyol compound.
- the specific composition of the polymer polyol compound is not particularly limited, and specifically, for example, polyalkylene glycols such as polyethylene glycol and polypropylene glycol, polyoxyethylene polyoxypropylene block copolymer, polyoxyethylene poly Polyoxyalkylenes such as oxypropylene ethylenediamine, glycerin derivatives such as polyglycerin and polyglycerin esters, vinyl polymers such as polyvinyl alcohol, polysaccharides such as galactomannan, glucomannan, and pullulan can be employed.
- polyvinyl alcohol is most preferably used.
- kinematic viscosity in this embodiment is a numerical value prescribed
- the concentration of the polymer polyol compound is 0.01 to 5% by weight, preferably 0.1 to 3% by weight, and more preferably 0.2 to 2% by weight.
- concentration is within such a range, the negative interaction can be particularly effectively suppressed. That is, when the concentration is more than 5% by weight, the negative interaction may not be sufficiently suppressed.
- concentration is less than 0.01% by weight, the effect of improving the wettability by the combination with the thickening action or the low molecular polyol compound may not be sufficiently exhibited.
- the contact lens composition according to the present embodiment for example, a contact lens multipurpose solution, a bactericidal solution, a cleaning solution, a protein cleaning / removing agent, a preserving solution, a rinsing solution, and an ophthalmic solution, as long as the inhibitory effect of negative interaction is not limited.
- a solution for contact lenses such as eyewash, mounting solution, packaging solution, hydration solution, etc.
- it can be used without any particular limitation.
- it may have a plurality of forms as a combination of the above forms such as contact lens mounting liquid and eye drops or eye drops and eye wash.
- the present embodiment is particularly suitably applied as a contact lens mounting solution, an eye drop solution, a packaging solution, and a contact lens multipurpose solution.
- the specific composition of the substance to be blended in the contact lens composition is not particularly limited as long as the negative interaction suppressing effect is not limited.
- any composition known in the art as a contact lens multipurpose solution, bactericidal solution, cleaning solution, protein cleaning / removing agent, preserving solution, rinsing solution, eye drops, eyewash solution, mounting solution, packaging solution, hydration solution, etc. can also be employed.
- additives can be appropriately added to the contact lens composition in addition to the above-described high-molecular polyol compound and low-molecular polyol compound. That is, known buffers, pH adjusters, preservatives / bactericides, surfactants, thickeners, tonicity agents, chelating agents, wetting agents, stabilizers, perfumes or cooling agents that can be included in each of the above liquids
- An agent, a drug, an antibacterial agent, vitamins, and the like can be blended in one or a combination of two or more.
- the above-mentioned low molecular polyol compound can also act as, for example, an isotonic agent in addition to the above-described action of suppressing the negative interaction. Therefore, the contact lens composition may be composed of only a low molecular polyol compound or a high molecular polyol compound, or may be added in combination with other additives.
- the buffer examples include boric acid, borax and borate buffer, carbonate buffer, citric acid and citrate buffer, carboxylic acids such as acetic acid, acids such as oxycarboxylic acid and salts thereof, aminoethyl Amino acids such as sulfonic acid, glycine, arginine, glutamic acid, ⁇ - aminocaproic acid, 2-amino-2-methyl-1,3-propane (AMP) buffer, tris (hydroxymethyl) aminomethane (Tris) buffer, Bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane (Bis-Tris), phosphoric acid and phosphate buffer, Good-Buffer, and the like.
- carboxylic acids such as acetic acid
- acids such as oxycarboxylic acid and salts thereof
- aminoethyl Amino acids such as sulfonic acid, glycine, arginine, glutamic acid, ⁇ - aminocaproic acid, 2-amino-2
- pH adjusting agent examples include hydrochloric acid, citric acid, acetic acid, sodium hydroxide, potassium hydroxide, sodium carbonate, sodium hydrogen carbonate, sodium hydrogen phosphate, sodium dihydrogen phosphate, phosphates, sulfuric acid and the like.
- preservatives and bactericides include sorbic acid, potassium sorbate, benzoic acid or salts thereof, ethyl paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate, methyl paraoxybenzoate, chlorobutanol, benzalkonium chloride, Polyhexamethylene biguanide (PHMB; polyhexanide hydrochloride), alkyldiaminoethylglycine hydrochloride, cetylpyridinium chloride (CPC), chlorhexidine, alexidine, chlorpheniramine or its salts, allantoin, chlorine dioxide, sodium perborate, polydronium chloride, etc. And the like.
- PHMB polyhexamethylene biguanide
- CPC cetylpyridinium chloride
- any of the conventionally known anionic surfactants, nonionic surfactants, and amphoteric surfactants can be appropriately employed.
- thickener examples include synthetic organic polymer compounds such as polyvinylpyrrolidone, polyacrylamide, poly (meth) acrylic acid, and Copolymer 845 (copolymer of polyvinylpyrrolidone and dimethylaminoethyl methacrylate), methylcellulose, ethylcellulose, and hydroxymethylcellulose.
- synthetic organic polymer compounds such as polyvinylpyrrolidone, polyacrylamide, poly (meth) acrylic acid, and Copolymer 845 (copolymer of polyvinylpyrrolidone and dimethylaminoethyl methacrylate), methylcellulose, ethylcellulose, and hydroxymethylcellulose.
- Cellulose derivatives such as hydroxypropylmethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, carboxyethylcellulose, starch derivatives, polysaccharides such as alginic acid, chitosan and their salts, various gums such as heteropolysaccharides, hyaluronic acid (salts) ), Mucopolysaccharides such as chondroitin sulfate (salt), and the like.
- tonicity agents examples include inorganic salts such as sodium chloride, potassium chloride, sodium bisulfite, sodium sulfite, magnesium chloride, potassium acetate, sodium acetate, sodium thiosulfate, and magnesium sulfate, and polyhydric alcohols such as propylene glycol and glycerin. Alternatively, ethers or esters thereof may be mentioned.
- chelating agent examples include ethylenediaminetetraacetic acid (EDTA) and salts thereof, ethylenediaminetetraacetic acid ⁇ disodium (EDTA ⁇ 2Na), ethylenediaminetetraacetic acid ⁇ 3sodium (EDTA ⁇ 3Na), ethylenediaminetetraacetic acid ⁇ 4sodium (EDTA ⁇ 4Na). ), Phytic acid, citric acid and the like.
- EDTA ethylenediaminetetraacetic acid
- EDTA ethylenediaminetetraacetic acid
- salts thereof examples include ethylenediaminetetraacetic acid ⁇ disodium (EDTA ⁇ 2Na), ethylenediaminetetraacetic acid ⁇ 3sodium (EDTA ⁇ 3Na), ethylenediaminetetraacetic acid ⁇ 4sodium (EDTA ⁇ 4Na).
- Phytic acid citric acid and the like.
- wetting agent examples include cellulose derivatives such as cationized cellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose and methylcellulose, lower or higher alcohols such as ethanol, isopropanol, oleyl alcohol and lauryl alcohol, almond oil, lanolin, olive oil, oleic acid and And / or its salts, oils and fats such as liquid paraffin, triglyceride, squalane, petrolatum, silicone oil, sesame oil, perilla oil, soybean oil, camellia oil, jojoba oil, corn oil, castor oil and the like.
- cellulose derivatives such as cationized cellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose and methylcellulose
- lower or higher alcohols such as ethanol, isopropanol, oleyl alcohol and lauryl alcohol
- almond oil lanolin
- olive oil oleic acid and And / or its salts
- oils and fats such as liquid paraffin, trig
- Stabilizers include ascorbic acid, sodium edetate, cyclodextrin, condensed phosphoric acid, sulfite, citric acid, dibutylhydroxytoluene, trometamol, sodium formaldehyde sulfoxylate (Longalite), tocopherol, sodium pyrosulfite, monoethanolamine, Examples thereof include aluminum monostearate.
- fragrance or refreshing agent examples include anethole, eugenol, camphor, chlorobutanol, geraniol, cineol, borneol, menthol, limonene, ryuunou, fennel oil, cool mint oil, cinnamon oil, spearmint oil, peppermint water, peppermint oil, peppermint Oil, bergamot oil, eucalyptus oil, rose oil and the like.
- Examples of the drug include cromoglycic acid, tranilast, chlorpheniramine maleate, diphenhydramine hydrochloride, amlexanox, ibudilast, pemirolast potassium, emedastine fumarate, ketotifen fumarate, olopatadine hydrochloride, ebastine, acitazanolast, levocabastine hydrochloride, etc.
- Anti-allergic agents glycyrrhizic acid and its salts, ⁇ -aminocaproic acid, allantoin, sodium azulenesulfonate, berberine chloride, berberine sulfate, zinc sulfate, zinc lactate, lysozyme, fluorometholone and other anti-inflammatory agents
- Blood vessels such as epinephrine, epinephrine hydrochloride, epinephrine hydrochloride, ephedrine hydrochloride, naphazoline hydrochloride, naphazoline nitrate, phenylephrine hydrochloride, tetrahydrozoline hydrochloride
- Agents focusing function improving agent such as neostigmine methylsulfate, betaxolol, timolol, dipivefrin, carteolol, Ratanopurasuto, Tafurupurasuto, Torabo
- Antibacterial agents include, for example, sulfamethoxazole, sulfamethoxazole sodium, sulfisoxazole, sulfisomidine sodium and other sulfa drugs, ofloxacin, norfloxacin, levofloxacin, gatifloxacin, moxifloxacin, tosufloxacin New quinolone antibacterial agents such as romefloxacin and ciprofloxacin, aminoglycoside antibacterial agents such as tobramycin, gentamicin, micronomycin, dibekacin and sisomycin, tetracycline antibacterial agents such as tetracycline and minocycline, and macrolide antibacterial agents such as erythromycin And chloramphenicol antibacterial agents such as chloramphenicol, and cephem antibacterial agents such as cefmenoxime.
- sulfamethoxazole sulfamethoxazole sodium,
- vitamins examples include vitamin A (including retinol palmitate, ⁇ -carotene, etc.), vitamin B2 (flavin adenine nucleotide, etc.), vitamin B6 (pyridoxine hydrochloride, etc.), vitamin B12 (cyanocobalamin, etc.), vitamin C ( Ascorbic acid and the like), vitamin Es (acetic acid-d- ⁇ -tocopherol and the like), panthenol and the like.
- vitamin A including retinol palmitate, ⁇ -carotene, etc.
- vitamin B2 flavin adenine nucleotide, etc.
- vitamin B6 pyridoxine hydrochloride, etc.
- vitamin B12 cyanocobalamin, etc.
- vitamin C Ascorbic acid and the like
- vitamin Es acetic acid-d- ⁇ -tocopherol and the like
- panthenol and the like examples include vitamin A (including retinol palmitate, ⁇ -carotene, etc.),
- the first liquid is a liquid used in contact with a contact lens, and is a multipurpose liquid for contact lenses, a bactericidal liquid, a cleaning liquid, a protein cleaning / removing agent, a preserving liquid, a rinsing liquid, an eye drop, an eye wash, It is a liquid selected from at least one of a mounting liquid, a packaging solution, a hydration liquid, and a tear liquid.
- Such first liquid is the above-mentioned contact lens multipurpose liquid, bactericidal liquid, cleaning liquid, protein cleaning / removing agent, preserving liquid, rinsing liquid, eye drops, eyewash liquid, mounting liquid, packaging solution, hydration liquid
- it may be configured to include only one kind of tears, or may be configured to include two or more kinds.
- a known cleaning liquid that exhibits only a cleaning action may be used, or a cleaning storage liquid that has both a cleaning action and a storage action may be used.
- a liquid obtained by mixing a known cleaning liquid and a storage liquid may be used.
- it may be an ophthalmic solution remaining in the conjunctival sac or a liquid agent obtained by mixing a multipurpose agent for contact lenses and tear fluid in the anterior ocular segment.
- the specific composition of the first liquid is not particularly limited as long as it does not limit the effect of suppressing the negative interaction of the contact lens composition. That is, the composition of known multipurpose liquids for contact lenses, bactericidal liquids, cleaning liquids, protein cleaning / removing agents, preservative liquids, rinsing liquids, eye drops, eyewash liquids, mounting liquids, packaging solutions, hydrating liquids, tears liquids, As long as the inhibitory effect of the negative interaction of the composition for contact lenses is not limited, it can be arbitrarily adopted.
- the first liquid is a known buffer, pH adjuster, preservative / bactericidal agent, surfactant, thickener, isotonic agent, which can be included in each of the above liquids,
- a chelating agent, a wetting agent, a stabilizer, a fragrance or a refreshing agent, a drug, an antibacterial agent, vitamins, and the like may be used alone or in combination.
- any of the additives that can be employed in the contact lens composition exemplified above can be employed without any particular limitation. To do.
- the composition for contact lenses according to this embodiment is suitably used especially for the first liquid composed of boric acid as a buffering agent and an antiseptic / bactericidal agent. That is, when the first liquid containing boric acid is mixed with a contact lens composition containing a polymer polyol compound such as polyvinyl alcohol, negative interactions such as formation of precipitation and gelation are caused. It is likely to occur. However, when the composition for contact lenses according to this embodiment is used, even if the first liquid contains boric acid and the composition for contact lenses contains polyvinyl alcohol, the composition for contact lenses is used. By including a low molecular polyol compound or the like, generation of negative interaction can be suppressed. As a result, it is possible to prevent irritation to the eyes of the user due to precipitates and the like, and it is also possible to prevent the boric acid buffering action, antiseptic action and bactericidal action contained in the first liquid from being inhibited.
- a polymer polyol compound such as polyvinyl alcohol
- the negative interaction referred to in the present embodiment is not limited to that caused by the interaction between boric acid and polyvinyl alcohol. That is, the negative interaction can occur as a result of the mixed contact between the first liquid and the contact lens composition. Precipitate formation, precipitate formation, gelation, viscosity reduction, contact lens surface water wetting It is sufficient that the action includes at least one of the property reductions, and it is not limited to a specific phenomenon due to mixing of specific substances.
- the first liquid only needs to be a solution that comes into contact with the contact lens at any stage.
- the first liquid and the contact lens composition are mixed, the first liquid is contacted.
- the lens may be in direct contact or may not be in contact. That is, the first liquid may contact the contact lens before or after the first liquid and the contact lens composition are mixed and contacted.
- the specific aspect in which the first liquid and the contact lens composition are mixed and contacted is not particularly limited. For example, in a state where the first liquid is stored in a storage container or the like together with the contact lens, the contact liquid composition is added thereto, so that the first liquid and the contact lens composition are mixed and brought into contact with each other.
- the contact lens composition may be mixed with the first liquid before the contact lens is immersed in the first liquid or when the contact lens is removed from the first liquid. May be.
- the first liquid and the contact lens composition may be in contact with each other in the vicinity of the user's cornea while the contact lens is attached to the user's eye.
- composition for contact lenses according to the present embodiment can be generated as a result of mixing the first liquid and the composition for contact lenses, formation of precipitates, formation of precipitates, gelation, decrease in viscosity, contact lens surface As long as it can suppress at least one action of reducing the wettability of water, only one negative interaction among these phenomena may be suppressed, or two or more It may be one that can suppress any negative interaction.
- the first embodiment of the present invention relating to a method for suppressing negative interaction is suitably implemented by using the contact lens composition according to one embodiment of the present invention relating to the above-described contact lens composition.
- the First at least one of contact lens multipurpose liquid, bactericidal liquid, cleaning liquid, protein cleaning / removing agent, preservative liquid, rinsing liquid, eye drops, eyewash liquid, mounting liquid, packaging solution, hydration liquid, and tear liquid
- composition for contact lenses according to one Embodiment of this invention regarding the composition for contact lenses mentioned above is mixed-contacted with such a 1st liquid.
- a second embodiment relating to a method for suppressing negative interaction in the first embodiment relating to the method for suppressing negative interaction described above, in particular, glucose, sucrose, lactose, maltose, trehalose, erythritol, Adopting a composition for contact lenses containing at least one selected from low molecular polyol compounds consisting of xylitol, maltitol, mannitol, sorbitol, to suitably suppress negative interaction with the first liquid Can do.
- Bioclen Zero (manufactured by Offtex Co., Ltd.), which is a commercially available multipurpose liquid for contact lenses, was employed.
- this bioclen zero contains 0.001 mg of polyhexanide hydrochloride (bactericidal agent) preparation in 1 ml.
- Table 1 the composition of the contact lens composition used in this experiment is as shown in Table 1 below.
- Examples 1 to 10 contain any one of mannitol, sorbitol, glucose, trehalose, and erythritol as a low molecular polyol compound.
- Comparative Examples 1 and 2 do not contain these low molecular polyol compounds.
- the contact lens compositions of Examples 1 to 10 and Comparative Examples 1 and 2 and the first liquid were mixed at a volume ratio of 1: 1. After mixing, x indicates that precipitation or precipitation occurred, no precipitation or precipitation occurs, but ⁇ indicates that the entire solution is cloudy, and ⁇ indicates that neither precipitation nor precipitation or clouding was observed. It was evaluated. The results are also shown in Table 1 below.
- Two types of polyvinyl alcohol are used. The negative interaction can be satisfactorily suppressed even when any of the two types of polyvinyl alcohols having a kinematic viscosity of about 30 mm 2 / s or less when used as a 4% by weight aqueous solution is used.
- kinematic viscosity of each polyvinyl alcohol is a manufacturer's standard value, and is measured in accordance with the viscosity measurement method of polyvinyl alcohol (partial saponification) defined by the pharmaceutical additive standard. That is, it is a numerical value measured at 20 ° C. using a Ubbelohde viscometer with a 4 wt% aqueous solution.
- boric acid is blended in bioclen zero, which is a commercially available multipurpose liquid for contact lenses, and negative interactions such as precipitation and precipitation seen in Comparative Examples 1 and 2, It is presumed that the mixed contact between boric acid and polyvinyl alcohol is the main factor.
- bioclen zero which is a commercially available multipurpose liquid for contact lenses, and negative interactions such as precipitation and precipitation seen in Comparative Examples 1 and 2, It is presumed that the mixed contact between boric acid and polyvinyl alcohol is the main factor.
- examples 1 to 10 even when the first liquid containing boric acid and the composition for contact lenses containing polyvinyl alcohol were mixed with a low molecular polyol compound such as mannitol, negative mutual It turns out that generation
- the first liquid used is as shown in Table 2 below. That is, as an example of a contact lens packaging solution, a packaging solution enclosed in a package of One Day Accuview (manufactured by Johnson & Johnson Co., Ltd.), a commercially available daily disposable soft contact lens, was employed. In addition, sodium chloride and a buffer agent are mix
- Rohto C Cube Cool Charge ⁇ (manufactured by Rohto Pharmaceutical Co., Ltd.) was employed as an example of commercially available eye drops (artificial tears) for contact lenses.
- This funnel C cube cool charge ⁇ contains 0.080% potassium chloride, 0.440% sodium chloride and 0.070% hydroxyethyl cellulose.
- Other additives include boric acid, borax, polyoxy Ethylene polyoxypropylene glycol, polyoxyethylene hydrogenated castor oil, Na edetate, 1-menthol, and pH regulator are blended.
- As the composition for contact lenses as shown in Table 2, the same compositions as in Example 8 and Comparative Example 2 used in Experimental Example 1 were used. These first liquid and contact lens composition were mixed at a volume ratio of 1: 1.
- the details of the first liquid and the contact lens composition used are as shown in Table 3 below. That is, the multipurpose liquid for contact lenses as the first liquid employs Bioclen Zero (manufactured by Off-Tex Co., Ltd.) in the same manner as in Experimental Example 1 described above, and as the eyewash, Ivon (Kobayashi Pharmaceutical Co., Ltd.) is a commercially available eyewash. Adopted). Since the composition of bioclen zero has already been described, description thereof is omitted here.
- Ivon an eyewash, contains 0.2% epsilon aminocaproic acid, 0.01% dipotassium glycyrrhizinate, 0.003% chlorpheniramine maleate, 0.01% pyridoxine hydrochloride (vitamin B6), tocopherol 0.005% acetate ester and 0.04% sodium chondroitin sulfate are blended.
- Other additives include boric acid, borax, sodium edetate hydrate, polysorbate 80, l-menthol, d-Borneol and pH adjuster are blended. That is, both of these multipurpose liquids and eyewashes contain boric acid.
- polyvinyl alcohol contained in the contact lens composition has a kinematic viscosity at 4 wt% aqueous solution, respectively 25 mm 2 / s, two types is 40 mm 2 / s is adopted.
- Examples 11 to 16 contain either mannitol or erythritol as a low molecular polyol compound.
- Example 4 As a first solution, an experiment was conducted to confirm the negative interaction suppression effect using a commercially available contact lens mounting solution containing polyvinyl alcohol and a contact lens composition containing boric acid. .
- Smile Contact Fine Fit manufactured by Lion Corporation
- other additives include Na edetate, cyclodextrin, benzalkonium chloride, and a pH adjuster. That is, this mounting solution contains polyvinyl alcohol but does not contain boric acid.
- the composition for contact lenses was made into the composition which does not contain polyvinyl alcohol, while both an Example and a comparative example contain boric acid. Furthermore, in Example 17, mannitol was blended as a low molecular polyol compound. These first liquid and contact lens composition were mixed at a volume ratio of 1: 1, respectively, and x and a precipitate or precipitate were produced. The white turbid one was evaluated as ⁇ , and the one in which neither precipitation nor precipitation generation nor white turbidity was observed was evaluated as ⁇ . The results are shown in Table 4 below.
- Comparative Example 5 using the composition for contact lenses that does not contain a low molecular polyol compound, the evaluation is x, and the first liquid containing polyvinyl alcohol, It can be seen that mixing with a composition for contact lenses containing boric acid results in the formation of a precipitate that is a negative interaction.
- Example 17 using the composition for contact lenses containing mannitol as the low-molecular-weight polyol compound the evaluation is ⁇ , and the negative interaction generated in Comparative Example 5 is effectively suppressed. . That is, even when the first liquid contains polyvinyl alcohol and the contact lens composition contains boric acid, the contact lens composition contains a low-molecular polyol compound, thereby causing a negative interaction. It can be confirmed that it can be suppressed.
- the details of the first liquid and the contact lens composition used are as shown in Table 5 below. That is, as the first-purpose multi-purpose liquid for contact lenses, Bioclen Zero (manufactured by Offtex Co., Ltd.), which is a commercially available multi-purpose liquid, was employed. Further, polyvinyl alcohol contained in the contact lens composition has a kinematic viscosity at 4 wt% aqueous solution was 5 mm 2 / s, respectively, 25 mm 2 / s, the three is 40 mm 2 / s is adopted. The first liquid and these contact lens compositions were mixed at a volume ratio of 1: 1. And the kinematic viscosity at 20 degreeC of the solution after mixing was measured using the Ubbelohde viscometer (made by Shibata Kagaku Co., Ltd.).
- Bioclen Zero manufactured by Offtex Co., Ltd.
- a contact lens composition having the composition shown in Table 6 below and a volume ratio of 1: 1.
- the ratio was mixed. After immersing a test lens (Menicon Co., Ltd., Menicon 2 Week Premio) for 4 hours in this mixed solution, the lens was taken out and the liquid adhering to the lens surface was gently wiped off. Thereafter, physiological saline was dropped on the lens front curve surface, and the contact angle of the lens surface with respect to the physiological saline was measured.
- the wettability improvement rate was calculated by the following calculation formula.
- Table 6 shows that the comparative example 10 does not contain polyvinyl alcohol, and it is set as the negative interaction by mixing with the boric acid contained in bioclen zero does not arise.
- Wettability improvement rate (%) ⁇ 1 ⁇ (actual value of contact angle) / (average contact angle in Comparative Example 10) ⁇ ⁇ 100
- Examples 24 and 25 in which these polyvinyl alcohols and low molecular polyol compounds are combined are higher than those in Examples 22 and 23 in which only the low molecular polyol compounds are combined. . That is, in Examples 24 and 25, a synergistic effect was produced by combining polyvinyl alcohol and a low molecular polyol compound, and Examples 22 and 23 in which only a low molecular polyol compound was blended without including polyvinyl alcohol were obtained. The wettability is dramatically improved as compared with Comparative Example 9 in which only No is added.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Eyeglasses (AREA)
- Detergent Compositions (AREA)
Abstract
Disclosed is a novel composition for contact lenses, which is capable of suppressing negative interactions that have been caused in cases where a conventional composition for contact lenses and a first liquid that is in contact with a contact lens are mixed and brought into contact with each other. The composition for contact lenses can suppress at least one negative interaction among the formation of a precipitate, the formation of a deposit, the gelation, the decrease in the viscosity, and the decrease in the water wettability of a contact lens surface which are caused when a composition for contact lenses and a first liquid that is in contact with a contact lens are mixed and brought into contact with each other.
Description
本発明は、コンタクトレンズ用組成物、及びそれを用いた負の相互作用の抑制方法に関する。
The present invention relates to a composition for contact lenses and a method for suppressing negative interaction using the composition.
コンタクトレンズは、製造されてからユーザーにより使用されるまでにおいて、また、ユーザーによる使用期間中において、様々な液に接触する。具体的には、例えば製造からユーザーによる使用まではパッケージ内において包装溶液に浸漬された状態で保存されることとなり、また、ユーザーによる使用時には、コンタクトレンズ用の装着液や点眼液と接触することとなる。さらに、装用を終えたコンタクトレンズをユーザーが洗浄する際には、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、すすぎ液等と接触することとなり、その後、保存液等の液中において保存される。このように、コンタクトレンズに対しては様々な液体が日常的に接触し、その過程において、各種の液体が混合された状態でコンタクトレンズに接触することも少なくない。
The contact lens is in contact with various liquids from the time it is manufactured until it is used by the user and during the period of use by the user. Specifically, for example, from manufacturing to use by the user, it is stored in a package soaked in the packaging solution, and when used by the user, it comes into contact with contact lens mounting solution or eye drops. It becomes. Furthermore, when the user cleans the worn contact lens, the user comes into contact with the contact lens multipurpose liquid, sterilizing liquid, cleaning liquid, rinsing liquid, and the like, and then stored in a liquid such as a storage liquid. As described above, various liquids come into contact with the contact lens on a daily basis, and in the process, various liquids are often mixed and contacted with the contact lens.
一方、コンタクトレンズ装用時における異物感や乾燥感を軽減するためのコンタクトレンズ用組成物としては、これまでに、引用文献1(特開2004-77953号公報),引用文献2(特開2006-39529号公報),引用文献3(特開2003-107416号公報)等に記載のコンタクトレンズ用組成物が考えられている。また、これらのコンタクトレンズ用組成物よりもさらに粘性を安定化させたものとして、引用文献4(特許第4267673号公報)に記載のコンタクトレンズ用組成物等も考案されている。
On the other hand, as a contact lens composition for reducing the feeling of foreign matter and dryness when wearing a contact lens, cited reference 1 (Japanese Patent Application Laid-Open No. 2004-77953) and cited reference 2 (Japanese Patent Application Laid-Open No. 2006-2007). No. 39529), cited reference 3 (Japanese Patent Laid-Open No. 2003-107416), and the like are considered. Moreover, the composition for contact lenses described in the cited reference 4 (patent 4267673) etc. are also devised as what stabilized viscosity more than these compositions for contact lenses.
しかしながら、このようなコンタクトレンズ用組成物を実際にユーザーらが使用する際には、何らかの原因によって、白濁や沈殿の発生や、溶液のゲル化など、様々な望ましくない現象が生じてしまう場合がある。その原因について発明者らが鋭意研究したところ、これらのコンタクトレンズ用組成物が実際にユーザーによって使用される際には、コンタクトレンズ用組成物が、コンタクトレンズに接触しているその他の液と接触して混合されることにより、その他の液との間で望ましくない相互作用(負の相互作用)が生じるためであることが判明したのである。
However, when such a contact lens composition is actually used by users, various undesired phenomena such as white turbidity, precipitation, and gelation of the solution may occur due to some cause. is there. The inventors have intensively studied the cause, and when these contact lens compositions are actually used by the user, the contact lens composition is in contact with other liquids in contact with the contact lens. It has been found that this is because an undesirable interaction (negative interaction) occurs with the other liquids by mixing.
すなわち、コンタクトレンズと接触して用いられる装着液等のコンタクトレンズ用組成物は、その実際の使用時においては、その他のコンタクトレンズに接触する各種の液と、相互に混合された状態となる。具体的には、例えば装用前のコンタクトレンズに対して装着液を滴下する場合には、既にコンタクトレンズに接触している各種の液体、例えば、コンタクトレンズ用多目的液剤、包装溶液、タンパク質洗浄・除去剤、保存液、洗浄液、すすぎ液等と、装着液とが接触して、相互に混合された状態となる。さらに、装着液を滴下したコンタクトレンズをユーザーが装用している状態では、装用者の涙液や、点眼液、洗眼液等とも接触して混合されることとなるのである。他には、点眼液を2種以上併用する場合や、保存液にタンパク質洗浄・除去剤を添加する場合も考えられる。
That is, a contact lens composition such as a mounting liquid used in contact with a contact lens is mixed with various liquids that come into contact with other contact lenses in actual use. Specifically, for example, when the mounting liquid is dropped on the contact lens before wearing, various liquids already in contact with the contact lens, for example, multipurpose liquids for contact lenses, packaging solutions, protein washing / removal The agent, the preserving liquid, the cleaning liquid, the rinsing liquid, and the mounting liquid come into contact with each other and are mixed with each other. Furthermore, in a state where the user wears the contact lens to which the wearing solution is dropped, the wearer's tear fluid, eye drops, eye wash, and the like are brought into contact and mixed. In other cases, two or more eye drops may be used in combination, or a protein washing / removing agent may be added to the preservation solution.
このように、装着液などのコンタクトレンズ用組成物を使用する際に生じる、コンタクトレンズ用組成物とその他の液との混合接触により生じる望ましくない相互作用、即ち、沈殿や析出物の生成、溶液のゲル化等の様々な望ましくない現象の発生については、これまで何等問題とされていなかった。それ故、このような現象を抑制する方法についても、如何なる対策も考案されていなかったのである。
As described above, undesired interactions caused by the contact contact between the contact lens composition and other liquids that occur when using the contact lens composition such as a mounting liquid, that is, the formation of precipitates and precipitates, solutions The occurrence of various undesirable phenomena such as gelation has not been regarded as a problem so far. Therefore, no countermeasure has been devised for the method of suppressing such a phenomenon.
ここにおいて、本発明は上述の如き事情を背景として為されたものであって、その解決課題とするところは、コンタクトレンズと接触する第一の液とコンタクトレンズ用組成物とが混合接触されることにより生じる負の相互作用の発生を抑制することができる、新規なコンタクトレンズ用組成物を提供することにある。
Here, the present invention has been made in the background as described above, and the problem to be solved is that the first liquid that comes into contact with the contact lens and the composition for contact lens are mixed and contacted. An object of the present invention is to provide a novel composition for contact lenses that can suppress the occurrence of negative interactions caused by the above.
さらに、本発明は、そのような負の相互作用を抑制するための新規な方法を提供することをも、目的とする。
Furthermore, an object of the present invention is to provide a novel method for suppressing such negative interaction.
以下、前述の如き課題を解決するために為された本発明の態様を記載する。なお、以下に記載の各態様において採用される構成要素は、可能な限り任意の組み合わせで採用可能である。
Hereinafter, embodiments of the present invention made to solve the above-described problems will be described. In addition, the component employ | adopted in each aspect as described below is employable by arbitrary combinations as much as possible.
すなわち、コンタクトレンズ用組成物に関する本発明の第一の態様は、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液に対して、混合接触されるコンタクトレンズ用組成物であって、前記第一の液との混合接触によって発生する、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つの負の相互作用が抑制されることを、特徴とする。
That is, the first aspect of the present invention relating to a contact lens composition is a multipurpose solution for contact lenses, a bactericidal solution, a cleaning solution, a protein cleaning / removing agent, a preserving solution, a rinsing solution, an ophthalmic solution, an eyewash solution, a mounting solution, a packaging. A contact lens composition that is mixedly contacted with a first liquid that comes into contact with a contact lens selected from at least one of a solution, a hydration treatment liquid, and a tear fluid. It is characterized in that at least one negative interaction among the formation of precipitates, the formation of precipitates, gelation, the decrease in viscosity, and the reduction in water wettability of the contact lens surface, which are generated by mixed contact with the water, is suppressed. And
本発明に従うコンタクトレンズ用組成物によれば、例えば装着液や点眼液等のコンタクトレンズ用組成物が、コンタクトレンズ用多目的液剤等の第一の液と混合接触しても、第一の液と負の相互作用、即ち、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減等の発生を抑制できることにより、このような負の相互作用に伴うコンタクトレンズ装用時の異物感や乾燥感の発生等を防ぐことが可能であり、装用感の低下を防止できる。また、このような負の相互作用の発生が抑制されることにより、コンタクトレンズ用組成物の物性や第一の液の溶液特性の劣化を防ぎ、それぞれの所期の作用を良好に発揮させることができる。また、本発明に従えば、上記の沈殿の生成等の現象以外にも、殺菌効力の低下、薬効の低下等の負の相互作用も抑制することが可能である。
According to the composition for contact lenses according to the present invention, for example, even if the contact lens composition such as a mounting liquid or eye drops is mixed and contacted with the first liquid such as the multipurpose liquid for contact lenses, Contact lenses associated with such negative interactions can be suppressed by suppressing the occurrence of negative interactions, that is, the formation of precipitates, the formation of precipitates, gelation, reduction in viscosity, reduction in water wettability of contact lens surfaces, etc. It is possible to prevent the appearance of foreign matter and dryness during wearing, and it is possible to prevent the wearing feeling from being lowered. In addition, by suppressing the occurrence of such negative interactions, the physical properties of the composition for contact lenses and the solution characteristics of the first liquid are prevented from being deteriorated, and the respective desired effects are exhibited well. Can do. Moreover, according to the present invention, in addition to the above-described phenomenon such as the formation of precipitates, it is possible to suppress negative interactions such as a decrease in bactericidal efficacy and a decrease in drug efficacy.
コンタクトレンズ用組成物に関する本発明の第二の態様は、前記第一の態様に係るコンタクトレンズ用組成物において、低分子ポリオール化合物を含むことを、特徴とする。
A second aspect of the present invention relating to a contact lens composition is characterized in that the contact lens composition according to the first aspect includes a low-molecular polyol compound.
本態様によれば、コンタクトレンズ用組成物と第一の液との混合接触によって生じる負の相互作用(沈殿の生成等)を、好適に抑制できる。
According to this aspect, it is possible to suitably suppress the negative interaction (precipitation generation or the like) caused by the mixed contact between the contact lens composition and the first liquid.
なお、従来の装着液等のコンタクトレンズ用組成物と、コンタクトレンズ用多目的液剤等の第一の液との混合接触によって、何故様々な負の相互作用が生じるのかは明らかではないが、一つの推測としては、第一の液等に含まれる例えばホウ酸等の成分と、コンタクトレンズ用組成物に含まれる成分とが、混合時において水素結合等によるネットワークを形成してしまうことが原因の一つと考えられる。そして、本態様に従えば、低分子ポリオール化合物のヒドロキシル基(-OH)が、このような水素結合等によるネットワークの形成に介入して阻害することにより、析出や白濁の発生、ゲル化等の現象を抑制できるのであろうと考えられている。
It is not clear why various negative interactions occur due to the mixed contact between the contact lens composition such as the conventional mounting liquid and the first liquid such as the multipurpose liquid for contact lenses. One possible cause is that a component such as boric acid contained in the first liquid and the like and a component contained in the contact lens composition form a network due to hydrogen bonding or the like during mixing. It is thought that. According to this embodiment, the hydroxyl group (—OH) of the low-molecular polyol compound intervenes and inhibits the formation of a network due to such a hydrogen bond, thereby causing precipitation, cloudiness, gelation, etc. It is thought that the phenomenon can be suppressed.
また、本態様に従い低分子ポリオール化合物を配合することにより、コンタクトレンズ表面の水濡れ性を向上させることもできる。これにより、コンタクトレンズ装着時の乾燥感を防ぐことができ、装用感をより向上させることが可能である。
In addition, the water wettability of the contact lens surface can be improved by blending the low molecular polyol compound according to this embodiment. Thereby, a dry feeling at the time of wearing a contact lens can be prevented, and the wearing feeling can be further improved.
コンタクトレンズ用組成物に関する本発明の三の態様は、前記第二の態様に係るコンタクトレンズ用組成物において、前記低分子ポリオール化合物が、グルコース、スクロース、ラクトース、マルトース、トレハロース、エリトリトール、キシリトール、マルチトール、マンニトール、ソルビトールから選択された少なくとも一つを含むことを、特徴とする。
Three aspects of the present invention relating to a contact lens composition are the contact lens composition according to the second aspect, wherein the low-molecular polyol compound is glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, multi It contains at least one selected from Toll, Mannitol, and Sorbitol.
本態様によれば、コンタクトレンズ用組成物と第一の液との混合接触によって生じる負の相互作用を、特に好適に抑制できる。即ち、低分子ポリオール化合物として上述の糖及び/又は糖アルコール類を採用することで、コンタクトレンズ用組成物の成分と、第一の液に含まれるホウ酸等の成分との間で引き起こされる負の相互作用を特に好適に阻害でき、その結果、析出の発生等による装用感の低下等を有効に防ぐことができる。
According to this embodiment, the negative interaction caused by the mixed contact between the contact lens composition and the first liquid can be particularly suitably suppressed. That is, by adopting the above-mentioned sugar and / or sugar alcohol as the low molecular weight polyol compound, negative effects caused between the components of the composition for contact lenses and the components such as boric acid contained in the first liquid. Can be particularly preferably inhibited, and as a result, it is possible to effectively prevent a decrease in wearing feeling due to the occurrence of precipitation or the like.
コンタクトレンズ用組成物に関する本発明の第四の態様は、前記第一乃至第三の何れか一つの態様に係るコンタクトレンズ用組成物において、高分子ポリオール化合物を含むことを、特徴とする。
A fourth aspect of the present invention relating to a contact lens composition is characterized in that the contact lens composition according to any one of the first to third aspects includes a polymer polyol compound.
本態様によれば、コンタクトレンズ用組成物の粘性を有効に向上でき、コンタクトレンズの装用感をより向上させることができる。即ち、従来のコンタクトレンズ用組成物では、粘性を増加させて装用感を向上させる等の目的で高分子ポリオール化合物を配合することが行われていたが、高分子ポリオール化合物が第一の液と混合接触されると、第一の液の成分と高分子ポリオール化合物との間で析出の生成や粘度の低下等の負の相互作用が発生し、却って装用感が低下してしまうことがあった。しかし、本態様に従えば、高分子ポリオール化合物を配合しても第一の液との負の相互作用の発生を抑制することができるため、粘度の低下等を防ぎ得、コンタクトレンズの装用感を有効に向上させることができる。なお、本態様は、上述の第二又は第三の態様と組み合わせて採用されることが望ましい。そして、本態様をこれら第二又は第三の態様と組み合わせて採用すれば、コンタクトレンズ表面の水濡れ性が特に好適に改善されるため、コンタクトレンズの装用感を一層改善できる。
According to this aspect, the viscosity of the contact lens composition can be effectively improved, and the wearing feeling of the contact lens can be further improved. That is, in the conventional contact lens composition, the polymer polyol compound has been blended for the purpose of increasing the viscosity and improving the wearing feeling, but the polymer polyol compound is used as the first liquid. When mixed and contacted, negative interactions such as the formation of precipitates and a decrease in viscosity occur between the components of the first liquid and the polymer polyol compound, and the feeling of wearing may decrease on the contrary. . However, according to this embodiment, even when a polymer polyol compound is blended, the negative interaction with the first liquid can be suppressed, so that a decrease in viscosity and the like can be prevented, and the wearing feeling of the contact lens can be prevented. Can be improved effectively. In addition, as for this aspect, it is desirable to employ | adopt in combination with the above-mentioned 2nd or 3rd aspect. And if this aspect is adopted in combination with these second or third aspects, the wettability of the contact lens surface is particularly preferably improved, so that the wearing feeling of the contact lens can be further improved.
コンタクトレンズ用組成物に関する本発明の第五の態様は、前記第四の態様に係るコンタクトレンズ用組成物において、前記高分子ポリオール化合物が、4重量%水溶液における動粘度が30mm2 /s以下であるポリビニルアルコールであることを、特徴とする。
A fifth aspect of the present invention relating to a contact lens composition is the contact lens composition according to the fourth aspect, wherein the polymer polyol compound has a kinematic viscosity of 30 mm 2 / s or less in a 4% by weight aqueous solution. It is characterized by being a certain polyvinyl alcohol.
本態様によれば、ポリビニルアルコールの作用によりコンタクトレンズ用組成物の粘性を向上させつつ、第一の液との負の相互作用を特に有効に防ぎ得て、装用感を良好に改善できる。即ち、4重量%水溶液における動粘度が30mm2 /s以下のポリビニルアルコールを採用すれば、例えば第一の液との負の相互作用による析出の生成と粘度の低下の二つの現象を何れも抑制できる。
According to this aspect, while improving the viscosity of the composition for contact lenses by the action of polyvinyl alcohol, it is possible to particularly effectively prevent the negative interaction with the first liquid and to improve the wearing feeling well. In other words, if polyvinyl alcohol having a kinematic viscosity of 30 mm 2 / s or less in a 4% by weight aqueous solution is employed, for example, both of the generation of precipitation due to negative interaction with the first liquid and the decrease in viscosity are suppressed. it can.
また、負の相互作用を抑制する方法に関する本発明の第一の態様は、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液に対して、コンタクトレンズ用組成物を混合接触することによって発生する負の相互作用を抑制する方法であって、前記コンタクトレンズ用組成物として請求項1~5の何れか一項に記載のコンタクトレンズ用組成物を用い、前記第一の液に混合接触することにより、前記負の相互作用として、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つを抑制することを、特徴とする。
In addition, the first aspect of the present invention relating to a method for suppressing negative interactions is a multipurpose solution for contact lenses, a bactericidal solution, a washing solution, a protein washing / removing agent, a preserving solution, a rinsing solution, an ophthalmic solution, an eyewash solution, and an attachment A negative liquid generated by mixing and contacting a contact lens composition with a first liquid that contacts a contact lens selected from at least one of a liquid, a packaging solution, a hydration solution, and a tear fluid A method for suppressing interaction, wherein the contact lens composition according to any one of claims 1 to 5 is used as the contact lens composition, and mixed contact with the first liquid is performed. The negative interaction is characterized by suppressing at least one of precipitate formation, precipitate formation, gelation, viscosity reduction, and contact lens surface water wettability reduction.
本態様によれば、上述のコンタクトレンズ用組成物に関する本発明の第一乃至第五の態様の何れか一つに記載のコンタクトレンズ用組成物を用いることで、コンタクトレンズに接触する第一の液とコンタクトレンズ用組成物との混合接触による負の相互作用を抑制し、装用感の低下や液性の劣化等を防止することができる。
According to this aspect, by using the contact lens composition according to any one of the first to fifth aspects of the present invention related to the contact lens composition described above, a first contact with the contact lens is achieved. Negative interaction due to mixed contact between the liquid and the contact lens composition can be suppressed, and deterioration of wearing feeling, deterioration of liquidity, and the like can be prevented.
また、負の相互作用を抑制する方法に関する本発明の第二の態様は、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液に対して、コンタクトレンズ用組成物を混合接触することによって発生する負の相互作用を抑制する方法であって、前記コンタクトレンズ用組成物について、グルコース、スクロース、ラクトース、マルトース、トレハロース、エリトリトール、キシリトール、マルチトール、マンニトール、ソルビトールからなる低分子ポリオール化合物から選択された少なくとも一つを含有せしめることにより、前記第一の液との混合接触による前記負の相互作用として、沈澱の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つを抑制することを、特徴とする。
In addition, the second aspect of the present invention relating to a method for suppressing negative interaction is a multipurpose solution for contact lenses, a bactericidal solution, a washing solution, a protein washing / removing agent, a preservation solution, a rinsing solution, an ophthalmic solution, an eyewash solution, and a wearing A negative liquid generated by mixing and contacting a contact lens composition with a first liquid that contacts a contact lens selected from at least one of a liquid, a packaging solution, a hydration solution, and a tear fluid A method for suppressing interaction, wherein the contact lens composition is at least one selected from low molecular polyol compounds consisting of glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, maltitol, mannitol, sorbitol. The negative contact due to the mixed contact with the first liquid. As interactions, formation of precipitation, precipitate formation, gelation, reduction in viscosity, to suppress at least one of the water-reducing wettability of the contact lens surface, characterized.
本態様によれば、低分子ポリオール化合物を含んだコンタクトレンズ用組成物を用いることで、コンタクトレンズに接触する第一の液とコンタクトレンズ用組成物との混合接触による負の相互作用を抑制することができる。
According to this aspect, by using the composition for contact lenses containing the low molecular polyol compound, negative interaction due to the mixed contact between the first liquid contacting the contact lenses and the composition for contact lenses is suppressed. be able to.
本発明によれば、コンタクトレンズに接触する第一の液と、コンタクトレンズ用組成物とを混合接触しても、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減等の負の相互作用が抑制される。これにより、負の相互作用に伴うコンタクトレンズの装用感の低下を防止することができる。
According to the present invention, even if the first liquid that contacts the contact lens and the contact lens composition are mixed and contacted, the formation of precipitates, the formation of precipitates, gelation, the decrease in viscosity, the contact lens surface Negative interactions such as reduced water wettability are suppressed. Thereby, it is possible to prevent a decrease in wearing feeling of the contact lens due to the negative interaction.
以下、本発明を更に具体的に明らかにするために、コンタクトレンズ用組成物に関する本発明及び負の相互作用を抑制する方法に関する本発明の実施形態について、詳細に説明する。
Hereinafter, in order to clarify the present invention more specifically, embodiments of the present invention related to a contact lens composition and a method for suppressing negative interaction will be described in detail.
コンタクトレンズ用組成物に関する本発明の一実施形態としてのコンタクトレンズ用組成物は、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液に対して混合接触されて使用される。そして、本実施形態に従うコンタクトレンズ用組成物は、この第一の液との混合接触によっても、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つの負の相互作用を抑制し得るものである。始めに、このようなコンタクトレンズ用組成物の特性について理解を容易とするために、従来のコンタクトレンズ用組成物を例にとって、本実施形態でいう第一の液と、この第一の液と従来のコンタクトレンズ用組成物との混合接触で生じる負の相互作用について説明する。
The contact lens composition as one embodiment of the present invention relating to a contact lens composition is a multipurpose solution for contact lenses, a bactericidal solution, a cleaning solution, a protein cleaning / removing agent, a storage solution, a rinsing solution, an ophthalmic solution, an eyewash solution, It is used after being mixed and contacted with a first liquid that comes into contact with a contact lens selected from at least one of a mounting liquid, a packaging solution, a hydration treatment liquid, and a tear liquid. And the composition for contact lenses according to the present embodiment also reduces the formation of precipitates, the formation of precipitates, gelation, the decrease in viscosity, and the water wettability of the contact lens surface by mixing contact with the first liquid. At least one of these negative interactions can be suppressed. First, in order to facilitate understanding of the characteristics of such a contact lens composition, the first liquid referred to in the present embodiment, the first liquid, The negative interaction that occurs in mixed contact with a conventional contact lens composition will be described.
従来から、コンタクトレンズ用の装着液や点眼液等として、様々なコンタクトレンズ用組成物が考えられている。そして、このようなコンタクトレンズ用組成物、例えば装着液等は、その他のコンタクトレンズ用の液剤、例えば保存液等と混合接触する機会が多い。具体的には、例えば装着液は、装用直前のコンタクトレンズに滴下して使用されることが多いが、装用直前のコンタクトレンズには、保存容器等から取り出された際に付着した保存液や洗浄液、あるいはそれらの混合物等が接触した状態となっている。そして、このようなコンタクトレンズに対して装着液が滴下されると、装着液はレンズ表面等において保存液や洗浄液等と相互に接触し、混合された状態となる。
Conventionally, various contact lens compositions have been considered as contact lens mounting solutions, eye drops, and the like. Such a contact lens composition, such as a mounting solution, has many opportunities to come into contact with other contact lens solutions such as a storage solution. Specifically, for example, the mounting liquid is often used by being dropped onto a contact lens immediately before wearing, but the storage liquid or cleaning liquid adhered to the contact lens immediately before wearing when it is taken out from a storage container or the like. Or a mixture thereof is in contact. When the mounting liquid is dropped onto such a contact lens, the mounting liquid comes into contact with the storage liquid, the cleaning liquid, and the like on the lens surface and is mixed.
そして、このようにしてコンタクトレンズ用組成物と第一の液との混合が生じると、従来のコンタクトレンズ用組成物では、コンタクトレンズ用組成物に含まれる成分と第一の液に含まれる成分との何らかの反応により、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減といった好ましくない現象が生じることがある。本実施形態では、これらの沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減等の好ましくない現象を総称して、負の相互作用と呼ぶ。なお、このような負の相互作用が生じると、コンタクトレンズの装用時に異物感や乾燥感を感じたり、視界がぼやける等、ユーザーにとって不快な現象が引き起こされるおそれがある。また、負の相互作用が生じることにより、例えば装着液としてのコンタクトレンズ用組成物が目的としていた水濡れ性の改善などの作用が低下したり、第一の液が有していた緩衝作用などの様々な作用が低下したりする可能性もある。
Then, when the contact lens composition and the first liquid are mixed in this way, in the conventional contact lens composition, the components included in the contact lens composition and the components included in the first liquid May cause undesired phenomena such as formation of precipitates, formation of precipitates, gelation, decrease in viscosity, and reduction in water wettability of contact lens surfaces. In the present embodiment, these unfavorable phenomena such as the formation of precipitates, the formation of precipitates, gelation, reduction in viscosity, and reduction in water wettability of the contact lens surface are collectively referred to as negative interactions. If such a negative interaction occurs, there is a risk that an unpleasant phenomenon will be caused to the user, such as a feeling of foreign matter or dryness when the contact lens is worn, or a blurred field of view. In addition, when negative interaction occurs, for example, the contact lens composition as a mounting liquid has an effect such as improvement of water wettability that is aimed at, or the first liquid has a buffering action. There is a possibility that the various effects of the decrease.
このような負の相互作用が何故生じるのかは未だ明らかではないが、このような負の相互作用は、特に、第一の液とコンタクトレンズ用組成物のうち少なくとも何れか一方にホウ酸が、他方にポリビニルアルコールが含まれており、これらが混合される場合において生じやすいことが、発明者らによって解明されている。なお、ホウ酸は緩衝剤及び防腐剤として、ポリビニルアルコールは増粘剤として、多くのコンタクトレンズ用液剤に添加されている一般的な物質である。このようなホウ酸又はポリビニルアルコールを含む第一の液とコンタクトレンズ用組成物とが混合されると、沈殿析出物の生成やゲル化等の、何らかの負の相互作用が特に引き起こされ易い。その結果、所期の緩衝作用や、装用感の向上作用を得られなくなるのである。また、このような沈殿や析出物の生成、ゲル化、濡れ性の低減等の負の相互作用は、ホウ酸とポリビニルアルコールとの混合だけでなく、その他の多様な物質の組み合わせによっても起こり得る。
It is not yet clear why such a negative interaction occurs. However, such a negative interaction is particularly caused by boric acid in at least one of the first liquid and the contact lens composition. On the other hand, the inventors have clarified that polyvinyl alcohol is contained and is likely to occur when these are mixed. Boric acid is a general substance added to many contact lens solutions as a buffer and preservative, and polyvinyl alcohol as a thickener. When such a first liquid containing boric acid or polyvinyl alcohol and the composition for contact lenses are mixed, some negative interaction such as formation of precipitates or gelation is particularly likely to occur. As a result, it is impossible to obtain the desired buffering action and improvement of wearing feeling. In addition, negative interactions such as the formation of precipitates and precipitates, gelation, and reduction of wettability can occur not only by mixing boric acid and polyvinyl alcohol, but also by combining various other substances. .
ここにおいて、本実施形態に従うコンタクトレンズ用組成物は、このような第一の液とコンタクトレンズ用組成物との混合接触により生じる負の相互作用を、好適に抑制できるものである。以下に、本実施形態についてさらに詳述する。
Here, the composition for contact lenses according to the present embodiment can suitably suppress the negative interaction caused by the mixed contact between the first liquid and the composition for contact lenses. Below, this embodiment is explained in full detail.
先ず、本実施形態におけるコンタクトレンズとしては、ハードコンタクトレンズ、酸素透過性ハードコンタクトレンズ、ソフトコンタクトレンズ、シリコーンハイドロゲルソフトコンタクトレンズ、ハイブリッドコンタクトレンズ(酸素透過性ハードコンタクトレンズとソフトコンタクトレンズとを組み合わせたコンタクトレンズ)、オルソケラトロジー用レンズ、おしゃれ用カラーコンタクトレンズ等、公知のコンタクトレンズが特に限定されることなく採用される。また、コンタクトレンズの使用形態も特に限定されない。即ち、1日又は1週間から数ヶ月間等の短期間のみ使用される使い捨て用のコンタクトレンズであってもよいし、より長期間使用される通常のコンタクトレンズであってもよい。
First, as a contact lens in this embodiment, a hard contact lens, an oxygen permeable hard contact lens, a soft contact lens, a silicone hydrogel soft contact lens, a hybrid contact lens (a combination of an oxygen permeable hard contact lens and a soft contact lens) Well-known contact lenses such as contact lenses), orthokeratology lenses, fashionable color contact lenses, and the like are used without particular limitation. Further, the usage form of the contact lens is not particularly limited. That is, it may be a disposable contact lens that is used only for a short period such as one day or one week to several months, or a normal contact lens that is used for a longer period.
コンタクトレンズ用組成物は、後述する第一の液との混合接触に際して、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つの負の相互作用を抑制し得る組成を有する。
When the contact lens composition is mixed and contacted with the first liquid described later, the contact lens composition has at least one negative effect of precipitation formation, precipitate formation, gelation, viscosity reduction, and contact lens surface water wettability reduction. It has a composition that can suppress the interaction.
コンタクトレンズ用組成物の具体的な組成は、負の相互作用を抑制できるものであれば、特に限定されるものではないが、好ましくは、コンタクトレンズ用組成物に例えば低分子ポリオール化合物が配合される。これにより、第一の液との負の相互作用を特に好適に抑制できる。また、このような低分子ポリオール化合物による負の相互作用の抑制作用は、コンタクトレンズ用組成物と第一の液のうちの少なくとも何れか一方にホウ酸が、他方にポリビニルアルコールが配合されている場合に、特に有効に発揮される。しかしながら、低分子ポリオール化合物による負の相互作用の抑制効果は、ホウ酸とポリビニルアルコールとの混合以外の原因による負の相互作用に対しても、有効に作用する。また、コンタクトレンズ用組成物に低分子ポリオール化合物を配合することにより、コンタクトレンズの濡れ性も向上されることから、コンタクトレンズの装用感も改善される。
The specific composition of the contact lens composition is not particularly limited as long as negative interaction can be suppressed, but preferably, for example, a low molecular polyol compound is blended in the contact lens composition. The Thereby, the negative interaction with the first liquid can be particularly suitably suppressed. In addition, such a low molecular polyol compound suppresses the negative interaction by mixing boric acid in at least one of the contact lens composition and the first liquid and polyvinyl alcohol in the other. In particular, it is particularly effective. However, the negative interaction suppression effect by the low-molecular polyol compound works effectively even for negative interactions caused by causes other than mixing of boric acid and polyvinyl alcohol. In addition, by blending the low molecular polyol compound with the contact lens composition, the wettability of the contact lens is also improved, so that the wearing feeling of the contact lens is also improved.
低分子ポリオール化合物は、特に、グルコース、スクロース、ラクトース、マルトース、トレハロース、エリトリトール、キシリトール、マルチトール、マンニトール、ソルビトールのうち少なくとも一つから選択されたものが採用されることが望ましい。これらの糖及び/又は糖アルコール類が採用されることにより、眼への刺激やコンタクトレンズの物性への影響を防ぎつつ、負の相互作用を特に有効に抑制できる。なお、低分子ポリオール化合物は、上述の物質のうちの一種のみが採用されていてもよいし、二種以上が組み合わされて採用されてもよい。また、好ましくはグルコース、トレハロース、エリトリトール、マンニトール、ソルビトールが採用され、より好ましくはエリトリトール、マンニトールが採用され、最も好ましくはマンニトールが採用される。
As the low molecular polyol compound, in particular, a compound selected from at least one of glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, maltitol, mannitol, and sorbitol is desirably employed. By adopting these sugars and / or sugar alcohols, negative interactions can be particularly effectively suppressed while preventing eye irritation and effects on physical properties of contact lenses. In addition, as for a low molecular polyol compound, only 1 type of the above-mentioned substance may be employ | adopted, and 2 or more types may be combined and employ | adopted. Moreover, glucose, trehalose, erythritol, mannitol, and sorbitol are preferably employed, more preferably erythritol and mannitol are employed, and most preferably mannitol is employed.
このような低分子ポリオール化合物は、0.1~10重量%の濃度で配合されることが望ましく、さらに望ましくは、0.5~5重量%の濃度で配合される。このような範囲内の濃度であれば、負の相互作用の抑制を特に有効に作用させることができる。即ち、濃度を10重量%よりも多くしていったとしても、負の相互作用の抑制効果は横這いとなり、無駄が生じてしまう場合がある。さらに、浸透圧が上昇することにより、コンタクトレンズの規格変化や、眼刺激が惹起される場合がある。一方、濃度が0.1重量%よりも少ない場合には、負の相互作用の抑制効果が充分に得ることができなくなるおそれがある。
Such a low-molecular polyol compound is desirably blended at a concentration of 0.1 to 10% by weight, and more desirably at a concentration of 0.5 to 5% by weight. If the concentration is within such a range, the negative interaction can be suppressed particularly effectively. That is, even if the concentration is increased to more than 10% by weight, the negative interaction suppressing effect becomes flat and waste may occur. Furthermore, when the osmotic pressure increases, there may be a case where the contact lens specification changes or eye irritation occurs. On the other hand, when the concentration is less than 0.1% by weight, there is a possibility that the effect of suppressing the negative interaction cannot be sufficiently obtained.
なお、低分子ポリオール化合物を、後述するポリビニルアルコール等の高分子ポリオール化合物と組み合わせて配合する場合には、高分子ポリオール化合物と低分子ポリオール化合物との濃度比が、1:1~1:10(高分子ポリオール化合物:低分子ポリオール化合物)とされることが好ましい。このような濃度比で低分子ポリオール化合物を配合することにより、より望ましい負の相互作用の抑制効果を得ることができる。
When the low molecular polyol compound is blended in combination with a high molecular polyol compound such as polyvinyl alcohol described later, the concentration ratio of the high molecular polyol compound to the low molecular polyol compound is 1: 1 to 1:10 ( High molecular polyol compound: low molecular polyol compound) is preferable. By blending the low-molecular polyol compound at such a concentration ratio, a more desirable negative interaction suppression effect can be obtained.
なお、従来のコンタクトレンズ用組成物と第一の液との混合接触によって様々な負の相互作用が生じる原因や、低分子ポリオール化合物の配合によってこのような負の相互作用が抑制されるメカニズムは、未だ明らかではないが、一つの推測としては、次のような仮説が考えられている。例えば、ポリビニルアルコールを含むコンタクトレンズ用組成物とホウ酸を含む第一の液との混合接触においては、第一の液等に含まれるホウ酸と、コンタクトレンズ用組成物に含まれるポリビニルアルコール等の成分とが、混合時において水素結合等によるネットワークを形成してしまうことが原因の一つと考えられている。そして、本実施形態に従えば、例えばマンニトール等の低分子ポリオール化合物がコンタクトレンズ用組成物に配合されることで、低分子ポリオール化合物のヒドロキシル基(-OH)を水素結合によるネットワークの形成に介入させて、その形成を阻害し得、その結果、析出や白濁の発生、ゲル化等の負の相互作用を抑制できるのではないかと推測されている。
The causes of various negative interactions caused by the mixed contact between the conventional contact lens composition and the first liquid, and the mechanism by which such negative interactions are suppressed by the blending of the low molecular polyol compound are as follows. Although not yet clear, the following hypothesis is considered as one guess. For example, in the mixed contact of the contact lens composition containing polyvinyl alcohol and the first liquid containing boric acid, boric acid contained in the first liquid and the like, polyvinyl alcohol contained in the contact lens composition, etc. One of the causes is considered to form a network due to hydrogen bonding or the like during mixing. Then, according to the present embodiment, for example, a low molecular polyol compound such as mannitol is blended in the contact lens composition, so that the hydroxyl group (—OH) of the low molecular polyol compound is involved in the formation of a network by hydrogen bonding. Therefore, it is speculated that the formation can be inhibited, and as a result, negative interactions such as precipitation, cloudiness, and gelation can be suppressed.
なお、上述のマンニトール等の低分子ポリオール化合物は、特に、コンタクトレンズ用組成物と第一の液のうち何れか一方にホウ酸が、他方にポリビニルアルコールが配合される場合に配合されることで、これらホウ酸とポリビニルアルコールとの混合による負の相互作用を特に有効に防止することが可能である。
The low-molecular polyol compound such as mannitol described above is blended particularly when boric acid is blended in one of the contact lens composition and the first liquid and polyvinyl alcohol is blended in the other. In addition, it is possible to particularly effectively prevent the negative interaction due to the mixture of boric acid and polyvinyl alcohol.
そして、本実施形態は、このようにポリビニルアルコール等の高分子ポリオール化合物を含むコンタクトレンズ用組成物において、特に好適に適用される。即ち、コンタクトレンズ用組成物には、コンタクトレンズ用組成物の粘性を向上させる増粘剤等として、ポリビニルアルコール等の高分子ポリオール化合物が配合されることが多い。ところが、このような高分子ポリオール化合物は、特にホウ酸などを含む第一の液と混合されると、析出の生成や、白濁化、ゲル化等の負の相互作用が発生してしまい、却って装用感が大きく低下してしまうことがある。特に、第一の液がホウ酸を含む場合には、ポリビニルアルコールを含むコンタクトレンズ用組成物との混合が生じると、沈殿の生成等の負の相互作用が生じることが知られている。しかし、本実施形態に従えば、ポリビニルアルコール等の高分子ポリオール化合物を含むコンタクトレンズ用組成物とホウ酸等を含む第一の液とが混合接触しても、コンタクトレンズ用組成物にマンニトール等の低分子ポリオール化合物が配合されていること等によって、負の相互作用を抑制できる。その結果、高分子ポリオール化合物の増粘作用が充分に発揮させることができるのである。
The present embodiment is particularly preferably applied to a contact lens composition containing a polymer polyol compound such as polyvinyl alcohol. That is, the composition for contact lenses is often blended with a polymer polyol compound such as polyvinyl alcohol as a thickener for improving the viscosity of the composition for contact lenses. However, when such a polymer polyol compound is mixed with a first liquid containing boric acid or the like, negative interactions such as precipitation, white turbidity, and gelation occur. Wearing feeling may be greatly reduced. In particular, in the case where the first liquid contains boric acid, it is known that when the first liquid is mixed with the composition for contact lenses containing polyvinyl alcohol, a negative interaction such as formation of a precipitate occurs. However, according to the present embodiment, even if the contact lens composition containing a polymer polyol compound such as polyvinyl alcohol and the first liquid containing boric acid are mixed and contacted, the contact lens composition has mannitol or the like. Negative interaction can be suppressed, for example, by blending the low molecular polyol compound. As a result, the thickening action of the polymer polyol compound can be sufficiently exerted.
さらに、このような高分子ポリオール化合物を前述の低分子ポリオール化合物と組み合わせて配合すると、これらの相乗効果によって、コンタクトレンズの濡れ性が大きく増強される。即ち、低分子ポリオール化合物は負の相互作用の抑制作用に加えて、ある程度の濡れ性の向上効果を有するが、これを高分子ポリオール化合物と組み合わせて配合することにより、濡れ性がさらに増大されるのである。従って、高分子ポリオール化合物と低分子ポリオール化合物とを組み合わせて配合することにより、コンタクトレンズの濡れ性を大きく向上させつつ、しかも第一の液との相互作用によるゲル化や析出の生成を抑えることができ、コンタクトレンズの装用感を有利に向上できるのである。従って、本実施形態に従うコンタクトレンズ用組成物には、高分子ポリオール化合物が配合されていることが望ましい。
Furthermore, when such a high-molecular polyol compound is combined with the aforementioned low-molecular polyol compound, the wettability of the contact lens is greatly enhanced by the synergistic effect. That is, the low-molecular polyol compound has an effect of improving the wettability to some extent in addition to the action of suppressing the negative interaction, but the wettability is further increased by blending it with the high-molecular polyol compound. It is. Therefore, by combining a high-molecular polyol compound and a low-molecular polyol compound in combination, the wettability of the contact lens is greatly improved and the formation of gelation and precipitation due to the interaction with the first liquid is suppressed. This can advantageously improve the wearing feeling of the contact lens. Therefore, it is desirable that the composition for contact lenses according to the present embodiment contains a polymer polyol compound.
高分子ポリオール化合物の具体的な組成は、特に限定されるものではなく、具体的には、例えばポリエチレングリコールやポリプロピレングリコール等のポリアルキレングリコール類、ポリオキシエチレンポリオキシプロピレンブロックコポリマー、ポリオキシエチレンポリオキシプロピレンエチレンジアミン等のポリオキシアルキレン類、ポリグリセリン、ポリグリセリンエステル等のグリセリン誘導体、ポリビニルアルコール等のビニル系高分子、ガラクトマンナン、グルコマンナン、プルラン等の多糖類等が採用され得る。なお、これらの高分子ポリオール化合物うちの一種のみが採用されていてもよいし、二種以上が組み合わされて採用されてもよい。そして、これらの物質のうち、最も望ましくはポリビニルアルコールが採用される。
The specific composition of the polymer polyol compound is not particularly limited, and specifically, for example, polyalkylene glycols such as polyethylene glycol and polypropylene glycol, polyoxyethylene polyoxypropylene block copolymer, polyoxyethylene poly Polyoxyalkylenes such as oxypropylene ethylenediamine, glycerin derivatives such as polyglycerin and polyglycerin esters, vinyl polymers such as polyvinyl alcohol, polysaccharides such as galactomannan, glucomannan, and pullulan can be employed. In addition, only 1 type of these polymer polyol compounds may be employ | adopted, and 2 or more types may be combined and employ | adopted. Of these substances, polyvinyl alcohol is most preferably used.
なお、高分子ポリオール化合物としてポリビニルアルコールを採用する場合には、4重量%水溶液における動粘度が30mm2 /s以下であるポリビニルアルコールが採用されることが望ましい。このようなポリビニルアルコールを採用すれば、第一の液がホウ酸を含んでいる場合にも、ホウ酸とポリビニルアルコールとの相互作用を主因とすると考えられる負の相互作用を、特に有効に抑えることが可能であり、例えば、析出の生成と粘度の低下の二つの現象を何れも抑制し得る。なお、本実施形態における動粘度の値は、医薬品添加物規格により定められたポリビニルアルコール(部分けん化)の粘度測定法に従い規定される数値である。具体的には、4重量%水溶液をウベローデ粘度計を使用して20℃で測定したものである。
In addition, when employ | adopting polyvinyl alcohol as a high molecular polyol compound, it is desirable to employ | adopt polyvinyl alcohol whose kinematic viscosity in 4 weight% aqueous solution is 30 mm < 2 > / s or less. When such polyvinyl alcohol is employed, even when the first liquid contains boric acid, the negative interaction that is considered to be mainly caused by the interaction between boric acid and polyvinyl alcohol is suppressed particularly effectively. For example, it is possible to suppress both of the two phenomena of formation of precipitation and decrease in viscosity. In addition, the value of kinematic viscosity in this embodiment is a numerical value prescribed | regulated according to the viscosity measuring method of polyvinyl alcohol (partial saponification) defined by the pharmaceutical additive specification. Specifically, a 4% by weight aqueous solution was measured at 20 ° C. using an Ubbelohde viscometer.
高分子ポリオール化合物の濃度は、0.01~5重量%、好ましくは0.1~3重量%、更に好ましくは0.2~2重量%とされる。このような範囲内の濃度であれば、負の相互作用を特に有効に抑制できる。即ち、濃度が5重量%よりも多いと、負の相互作用を充分に抑制しきれない場合がある。一方、濃度が0.01重量%よりも少ない場合には、増粘作用や低分子ポリオール化合物との組み合わせによる濡れ性の向上効果が充分に発揮され得ないおそれがある。
The concentration of the polymer polyol compound is 0.01 to 5% by weight, preferably 0.1 to 3% by weight, and more preferably 0.2 to 2% by weight. When the concentration is within such a range, the negative interaction can be particularly effectively suppressed. That is, when the concentration is more than 5% by weight, the negative interaction may not be sufficiently suppressed. On the other hand, when the concentration is less than 0.01% by weight, the effect of improving the wettability by the combination with the thickening action or the low molecular polyol compound may not be sufficiently exhibited.
本実施形態に従うコンタクトレンズ用組成物は、負の相互作用の抑制効果を制限しない限りにおいて、例えばコンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液等のコンタクトレンズ用の液剤として、特に限定されることなく用いられ得る。さらには、コンタクトレンズ装着液と点眼液、あるいは点眼液と洗眼液等、上記形態の組み合わせとして、複数の形態を併せ持つものであってもよい。そして、本実施形態は、コンタクトレンズ用の装着液、点眼液、包装溶液、コンタクトレンズ用多目的液剤として特に好適に適用される。
The contact lens composition according to the present embodiment, for example, a contact lens multipurpose solution, a bactericidal solution, a cleaning solution, a protein cleaning / removing agent, a preserving solution, a rinsing solution, and an ophthalmic solution, as long as the inhibitory effect of negative interaction is not limited. As a solution for contact lenses, such as eyewash, mounting solution, packaging solution, hydration solution, etc., it can be used without any particular limitation. Furthermore, it may have a plurality of forms as a combination of the above forms such as contact lens mounting liquid and eye drops or eye drops and eye wash. The present embodiment is particularly suitably applied as a contact lens mounting solution, an eye drop solution, a packaging solution, and a contact lens multipurpose solution.
また、コンタクトレンズ用組成物に配合される物質の具体的な組成は、負の相互作用の抑制効果を制限しない限りにおいて、特に限定されない。例えば、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液等として公知の組成配合が、何れも採用され得る。
Further, the specific composition of the substance to be blended in the contact lens composition is not particularly limited as long as the negative interaction suppressing effect is not limited. For example, any composition known in the art as a contact lens multipurpose solution, bactericidal solution, cleaning solution, protein cleaning / removing agent, preserving solution, rinsing solution, eye drops, eyewash solution, mounting solution, packaging solution, hydration solution, etc. Can also be employed.
従って、より具体的には、コンタクトレンズ用組成物には、上述の高分子ポリオール化合物や低分子ポリオール化合物の他に、その他の添加剤が適宜添加され得る。即ち、上記の各液剤に含まれ得る公知の緩衝剤、pH調整剤、防腐剤・殺菌剤、界面活性剤、増粘剤、等張化剤、キレート剤、湿潤剤、安定剤、香料又は清涼化剤、薬剤、抗菌剤、ビタミン類等が、一種又は二種以上組み合わされて配合され得る。
Therefore, more specifically, other additives can be appropriately added to the contact lens composition in addition to the above-described high-molecular polyol compound and low-molecular polyol compound. That is, known buffers, pH adjusters, preservatives / bactericides, surfactants, thickeners, tonicity agents, chelating agents, wetting agents, stabilizers, perfumes or cooling agents that can be included in each of the above liquids An agent, a drug, an antibacterial agent, vitamins, and the like can be blended in one or a combination of two or more.
なお、上述の低分子ポリオール化合物は、上述の負の相互作用の抑制作用の他にも、例えば等張化剤等としても作用し得る。それ故、コンタクトレンズ用組成物を低分子ポリオール化合物や高分子ポリオール化合物だけで構成してもよいし、その他の添加剤を別途組み合わせて加えてもよい。
In addition, the above-mentioned low molecular polyol compound can also act as, for example, an isotonic agent in addition to the above-described action of suppressing the negative interaction. Therefore, the contact lens composition may be composed of only a low molecular polyol compound or a high molecular polyol compound, or may be added in combination with other additives.
緩衝剤としては、例えばホウ酸、ホウ砂及びホウ酸塩緩衝剤、炭酸塩緩衝剤、クエン酸及びクエン酸塩緩衝剤、酢酸等のカルボン酸類、オキシカルボン酸等の酸やその塩、アミノエチルスルホン酸、グリシン、アルギニン、グルタミン酸等のアミノ酸類、ε- アミノカプロン酸、2-アミノ-2-メチル-1,3-プロパン(AMP)緩衝剤、トリス(ヒドロキシメチル)アミノメタン(Tris)緩衝液、ビス(2-ヒドロキシエチル)イミノトリス(ヒドロキシメチル)メタン(Bis-Tris)、リン酸及びリン酸塩緩衝剤、Good-Buffer等が挙げられる。
Examples of the buffer include boric acid, borax and borate buffer, carbonate buffer, citric acid and citrate buffer, carboxylic acids such as acetic acid, acids such as oxycarboxylic acid and salts thereof, aminoethyl Amino acids such as sulfonic acid, glycine, arginine, glutamic acid, ε- aminocaproic acid, 2-amino-2-methyl-1,3-propane (AMP) buffer, tris (hydroxymethyl) aminomethane (Tris) buffer, Bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane (Bis-Tris), phosphoric acid and phosphate buffer, Good-Buffer, and the like.
pH調整剤としては、例えば塩酸、クエン酸、酢酸、水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸水素ナトリウム、リン酸水素ナトリウム、リン酸二水素ナトリウム等のリン酸塩、硫酸等が挙げられる。
Examples of the pH adjusting agent include hydrochloric acid, citric acid, acetic acid, sodium hydroxide, potassium hydroxide, sodium carbonate, sodium hydrogen carbonate, sodium hydrogen phosphate, sodium dihydrogen phosphate, phosphates, sulfuric acid and the like. .
防腐剤・殺菌剤としては、例えばソルビン酸、ソルビン酸カリウム、安息香酸或いはその塩、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸メチル、クロロブタノール、塩化ベンザルコニウム、ポリヘキサメチレンビグアニド(PHMB;塩酸ポリヘキサニド)、塩酸アルキルジアミノエチルグリシン、塩化セチルピリジニウム(CPC)、クロルヘキシジン、アレキシジン、クロルフェニラミン又はその塩、アラントイン、二酸化塩素、過ホウ酸ナトリウム、塩化ポリドロニウム等のポリクオタニウム類等が挙げられる。
Examples of preservatives and bactericides include sorbic acid, potassium sorbate, benzoic acid or salts thereof, ethyl paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate, methyl paraoxybenzoate, chlorobutanol, benzalkonium chloride, Polyhexamethylene biguanide (PHMB; polyhexanide hydrochloride), alkyldiaminoethylglycine hydrochloride, cetylpyridinium chloride (CPC), chlorhexidine, alexidine, chlorpheniramine or its salts, allantoin, chlorine dioxide, sodium perborate, polydronium chloride, etc. And the like.
界面活性剤としては、従来から公知のアニオン系界面活性剤、ノニオン系界面活性剤、両性界面活性剤の何れもが、適宜に採用され得るのであり、そのような界面活性剤としては、例えばポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルフェニルエーテルホルムアルデヒド縮合物、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレンステロール、ポリオキシエチレン水素添加ステロール、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンラノリンアルコール、ポリオキシエチレンアルキルアミン、ポリオキシエチレンアルキルアミド、ポリオキシエチレンアルキルエーテルリン酸、ポリソルベート、ポリオキシエチレンアルキルエーテルカルボン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、アルキル脂肪酸塩、アルキルリン酸塩、N-アシルタウリン塩、アルキルグルタミン酸塩、アルキルグリシン塩、アルキルアラニン塩、ココイル脂肪酸アルギニン、アルキル硫酸塩、アルキルスルホン酸塩、酢酸ベタイン型両面活性剤、アルキルオキシヒドロキシプロピルアルギニン塩、ココイルアルギニンエチルPCA等が挙げられる。
As the surfactant, any of the conventionally known anionic surfactants, nonionic surfactants, and amphoteric surfactants can be appropriately employed. Glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl phenyl ether formaldehyde condensate, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl phenyl ether, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbite fatty acid ester, poly Oxyethylene castor oil, polyoxyethylene sterol, polyoxyethylene hydrogenated sterol, polyoxyethylene fatty acid ester, polyoxyethylene polyoxypropylene alkyl ether, polio Siethylene lanolin alcohol, polyoxyethylene alkylamine, polyoxyethylene alkylamide, polyoxyethylene alkyl ether phosphate, polysorbate, polyoxyethylene alkyl ether carboxylate, polyoxyethylene alkyl ether sulfate, alkyl fatty acid salt, alkyl phosphorus Acid salt, N-acyl taurine salt, alkyl glutamate salt, alkyl glycine salt, alkyl alanine salt, cocoyl fatty acid arginine, alkyl sulfate salt, alkyl sulfonate salt, betaine acetate type double active agent, alkyloxyhydroxypropyl arginine salt, cocoyl arginine salt Examples include ethyl PCA.
増粘剤としては、例えばポリビニルピロリドン、ポリアクリルアミド、ポリ(メタ)アクリル酸、Copolymer845(ポリビニルピロリドンとジメチルアミノエチルメタクリレートの共重合ポリマー)等の合成有機高分子化合物等や、メチルセルロース、エチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロース、カルボキシエチルセルロースなどのセルロース誘導体や、スターチ誘導体、アルギン酸、キトサン及びそれらの塩等の多糖類、ヘテロ多糖類等の種々のガム類や、ヒアルロン酸(塩)、コンドロイチン硫酸(塩)等のムコ多糖類等が挙げられる。
Examples of the thickener include synthetic organic polymer compounds such as polyvinylpyrrolidone, polyacrylamide, poly (meth) acrylic acid, and Copolymer 845 (copolymer of polyvinylpyrrolidone and dimethylaminoethyl methacrylate), methylcellulose, ethylcellulose, and hydroxymethylcellulose. , Cellulose derivatives such as hydroxypropylmethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, carboxyethylcellulose, starch derivatives, polysaccharides such as alginic acid, chitosan and their salts, various gums such as heteropolysaccharides, hyaluronic acid (salts) ), Mucopolysaccharides such as chondroitin sulfate (salt), and the like.
等張化剤としては、例えば塩化ナトリウム、塩化カリウム、亜硫酸水素ナトリウム、亜硫酸ナトリウム、塩化マグネシウム、酢酸カリウム、酢酸ナトリウム、チオ硫酸ナトリウム、硫酸マグネシウム等の無機塩類、プロピレングリコール、グリセリン等の多価アルコール若しくはそのエーテル又はエステル等が挙げられる。
Examples of tonicity agents include inorganic salts such as sodium chloride, potassium chloride, sodium bisulfite, sodium sulfite, magnesium chloride, potassium acetate, sodium acetate, sodium thiosulfate, and magnesium sulfate, and polyhydric alcohols such as propylene glycol and glycerin. Alternatively, ethers or esters thereof may be mentioned.
キレート剤としては、例えばエチレンジアミン四酢酸(EDTA)及びその塩、エチレンジアミン四酢酸・2ナトリウム(EDTA・2Na)、エチレンジアミン四酢酸・3ナトリウム(EDTA・3Na)、エチレンジアミン四酢酸・4ナトリウム(EDTA・4Na)、フィチン酸、クエン酸等が挙げられる。
Examples of the chelating agent include ethylenediaminetetraacetic acid (EDTA) and salts thereof, ethylenediaminetetraacetic acid · disodium (EDTA · 2Na), ethylenediaminetetraacetic acid · 3sodium (EDTA · 3Na), ethylenediaminetetraacetic acid · 4sodium (EDTA · 4Na). ), Phytic acid, citric acid and the like.
湿潤剤としては、例えばカチオン化セルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース及びメチルセルロース等のセルロース誘導体、エタノール、イソプロパノール、オレイルアルコール、ラウリルアルコール等の低級あるいは高級アルコール類、アルモンド油、ラノリン、オリーブ油、オレイン酸及び/又はその塩、流動パラフィン、トリグリセリド、スクワラン、ワセリン、シリコン油、ゴマ油、シソ油、ダイズ油、ツバキ油、ホホバ油、トウモロコシ油、ヒマシ油等の油脂類等が挙げられる。
Examples of the wetting agent include cellulose derivatives such as cationized cellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose and methylcellulose, lower or higher alcohols such as ethanol, isopropanol, oleyl alcohol and lauryl alcohol, almond oil, lanolin, olive oil, oleic acid and And / or its salts, oils and fats such as liquid paraffin, triglyceride, squalane, petrolatum, silicone oil, sesame oil, perilla oil, soybean oil, camellia oil, jojoba oil, corn oil, castor oil and the like.
安定剤としては、アスコルビン酸、エデト酸ナトリウム、シクロデキストリン、縮合リン酸、亜硫酸塩、クエン酸、ジブチルヒドロキシトルエン、トロメタモール、ナトリウムホルムアルデヒドスルホキシレート(ロンガリット)、トコフェロール、ピロ亜硫酸ナトリウム、モノエタノールアミン、モノステアリン酸アルミニウム等が挙げられる。
Stabilizers include ascorbic acid, sodium edetate, cyclodextrin, condensed phosphoric acid, sulfite, citric acid, dibutylhydroxytoluene, trometamol, sodium formaldehyde sulfoxylate (Longalite), tocopherol, sodium pyrosulfite, monoethanolamine, Examples thereof include aluminum monostearate.
香料又は清涼化剤としては、例えばアネトール、オイゲノール、カンフル、クロロブタノール、ゲラニオール、シネオール、ボルネオール、メントール、リモネン、リュウノウ、ウイキョウ油、クールミント油、ケイヒ油、スペアミント油、ハッカ水、ハッカ油、ペパーミント油、ベルガモット油、ユーカリ油、ローズ油などが挙げられる。
Examples of the fragrance or refreshing agent include anethole, eugenol, camphor, chlorobutanol, geraniol, cineol, borneol, menthol, limonene, ryuunou, fennel oil, cool mint oil, cinnamon oil, spearmint oil, peppermint water, peppermint oil, peppermint Oil, bergamot oil, eucalyptus oil, rose oil and the like.
薬剤としては、例えばクロモグリク酸、トラニラスト、マレイン酸クロルフェニラミン、塩酸ジフェンヒドラミン、アンレキサノクス、イブジラスト、ペミロラストカリウム、フマル酸エメダスチン、フマル酸ケトチフェン、塩酸オロパタジン、エバスチン、アシタザノラスト、レボカバスチン、塩酸セチリジン等の抗アレルギー剤や、グリチルリチン酸及びその塩、ε-アミノカプロン酸、アラントイン、アズレンスルホン酸ナトリウム、塩化ベルベリン、硫酸ベルベリン、硫酸亜鉛、乳酸亜鉛、リゾチーム、フルオロメトロン等のステロイド系または非ステロイド系の消炎剤、エピネフィリン、塩酸エピネフィリン、塩酸エフェドリン、塩酸ナファゾリン、硝酸ナファゾリン、塩酸フェニレフリン、塩酸テトラヒドロゾリン等の血管収縮剤、メチル硫酸ネオスチグミン等のピント調節機能改善剤、ベタキソロール、チモロール、ジピベフリン、カルテオロール、ラタノプラスト、タフルプラスト、トラボプラスト、ニプラジロール、レボブノール等の眼圧降下剤等が挙げられる。
Examples of the drug include cromoglycic acid, tranilast, chlorpheniramine maleate, diphenhydramine hydrochloride, amlexanox, ibudilast, pemirolast potassium, emedastine fumarate, ketotifen fumarate, olopatadine hydrochloride, ebastine, acitazanolast, levocabastine hydrochloride, etc. Anti-allergic agents, glycyrrhizic acid and its salts, ε-aminocaproic acid, allantoin, sodium azulenesulfonate, berberine chloride, berberine sulfate, zinc sulfate, zinc lactate, lysozyme, fluorometholone and other anti-inflammatory agents Blood vessels such as epinephrine, epinephrine hydrochloride, epinephrine hydrochloride, ephedrine hydrochloride, naphazoline hydrochloride, naphazoline nitrate, phenylephrine hydrochloride, tetrahydrozoline hydrochloride Agents, focusing function improving agent such as neostigmine methylsulfate, betaxolol, timolol, dipivefrin, carteolol, Ratanopurasuto, Tafurupurasuto, Torabopurasuto, nipradilol, include ocular hypotensive agents such as Rebobunoru.
抗菌剤としては、例えばスルファメトキサゾール、スルファメトキサゾールナトリウム、スルフィソキサゾール、スルフィソミジンナトリウム等のサルファ剤、オフロキサシン、ノルフロキサシン、レボフロキサシン、ガチフロキサシン、モキシフロキサシン、トスフロキサシン、ロメフロキサシン、シプロフロキサシン等のニューキノロン系抗菌剤、トブラマイシン、ゲンタマイシン、ミクロノマイシン、ジベカシン、シソマイシン等のアミノグリコシド系抗菌剤、テトラサイクリン、ミノサイクリン等のテトラサイクリン系抗菌剤、エリスロマイシン等のマクロライド系抗菌剤、クロラムフェニコール等のクロラムフェニコール系抗菌剤、セフメノキシム等のセフェム系抗菌剤等が挙げられる。
Antibacterial agents include, for example, sulfamethoxazole, sulfamethoxazole sodium, sulfisoxazole, sulfisomidine sodium and other sulfa drugs, ofloxacin, norfloxacin, levofloxacin, gatifloxacin, moxifloxacin, tosufloxacin New quinolone antibacterial agents such as romefloxacin and ciprofloxacin, aminoglycoside antibacterial agents such as tobramycin, gentamicin, micronomycin, dibekacin and sisomycin, tetracycline antibacterial agents such as tetracycline and minocycline, and macrolide antibacterial agents such as erythromycin And chloramphenicol antibacterial agents such as chloramphenicol, and cephem antibacterial agents such as cefmenoxime.
ビタミン類としては、例えばビタミンA類(パルミチン酸レチノール、β-カロテン等を含む)、ビタミンB2(フラビンアデニンヌクレオチド等)、ビタミンB6(塩酸ピリドキシン等)、ビタミンB12(シアノコバラミン等)、ビタミンC類(アスコルビン酸等)、ビタミンE類(酢酸-d-α-トコフェロール等)、パンテノール等が挙げられる。
Examples of vitamins include vitamin A (including retinol palmitate, β-carotene, etc.), vitamin B2 (flavin adenine nucleotide, etc.), vitamin B6 (pyridoxine hydrochloride, etc.), vitamin B12 (cyanocobalamin, etc.), vitamin C ( Ascorbic acid and the like), vitamin Es (acetic acid-d-α-tocopherol and the like), panthenol and the like.
一方、第一の液は、コンタクトレンズと接触して用いられる液体であって、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択される液である。
On the other hand, the first liquid is a liquid used in contact with a contact lens, and is a multipurpose liquid for contact lenses, a bactericidal liquid, a cleaning liquid, a protein cleaning / removing agent, a preserving liquid, a rinsing liquid, an eye drop, an eye wash, It is a liquid selected from at least one of a mounting liquid, a packaging solution, a hydration liquid, and a tear liquid.
このような第一の液は、上述のコンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの一種のみを含んで構成されていてもよいし、二種以上を含んで構成されていてもよい。具体的には、例えば洗浄作用のみを発揮する公知の洗浄液であってもよいし、洗浄作用と保存作用を兼ね備えた洗浄保存液であってもよい。また、例えば公知の洗浄液と保存液等とを混合した液体であってもよい。さらには、結膜嚢に残留した点眼液あるいはコンタクトレンズ用多目的剤と涙液とが前眼部にて混合した液剤であっても良い。
Such first liquid is the above-mentioned contact lens multipurpose liquid, bactericidal liquid, cleaning liquid, protein cleaning / removing agent, preserving liquid, rinsing liquid, eye drops, eyewash liquid, mounting liquid, packaging solution, hydration liquid In addition, it may be configured to include only one kind of tears, or may be configured to include two or more kinds. Specifically, for example, a known cleaning liquid that exhibits only a cleaning action may be used, or a cleaning storage liquid that has both a cleaning action and a storage action may be used. Further, for example, a liquid obtained by mixing a known cleaning liquid and a storage liquid may be used. Further, it may be an ophthalmic solution remaining in the conjunctival sac or a liquid agent obtained by mixing a multipurpose agent for contact lenses and tear fluid in the anterior ocular segment.
また、第一の液の具体的な組成は、コンタクトレンズ用組成物の負の相互作用の抑制効果を制限しない限りにおいて、特に限定されるものではない。即ち、公知のコンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液の組成が、コンタクトレンズ用組成物の負の相互作用の抑制効果を制限しない限りにおいて、任意に採用され得る。
In addition, the specific composition of the first liquid is not particularly limited as long as it does not limit the effect of suppressing the negative interaction of the contact lens composition. That is, the composition of known multipurpose liquids for contact lenses, bactericidal liquids, cleaning liquids, protein cleaning / removing agents, preservative liquids, rinsing liquids, eye drops, eyewash liquids, mounting liquids, packaging solutions, hydrating liquids, tears liquids, As long as the inhibitory effect of the negative interaction of the composition for contact lenses is not limited, it can be arbitrarily adopted.
従って、より具体的には、第一の液は、上記の各液剤に含まれ得る公知の緩衝剤、pH調整剤、防腐剤・殺菌剤、界面活性剤、増粘剤、等張化剤、キレート剤、湿潤剤、安定剤、香料又は清涼化剤、薬剤、抗菌剤、ビタミン類等が一種又は二種以上組み合わされて配合され得る。なお、これらの添加剤の具体的な成分としては、先に例示したコンタクトレンズ用組成物に採用され得る添加剤が、何れも特に限定されることなく採用され得るため、ここでの例示は省略する。
Therefore, more specifically, the first liquid is a known buffer, pH adjuster, preservative / bactericidal agent, surfactant, thickener, isotonic agent, which can be included in each of the above liquids, A chelating agent, a wetting agent, a stabilizer, a fragrance or a refreshing agent, a drug, an antibacterial agent, vitamins, and the like may be used alone or in combination. In addition, as specific components of these additives, any of the additives that can be employed in the contact lens composition exemplified above can be employed without any particular limitation. To do.
そして、本実施形態に従うコンタクトレンズ用組成物は、特に、緩衝剤及び防腐剤・殺菌剤としてホウ酸を含んで構成された第一の液に対して好適に用いられる。即ち、ホウ酸を含んだ第一の液は、特に、ポリビニルアルコール等の高分子ポリオール化合物等を含むコンタクトレンズ用組成物と混合されると、析出の生成やゲル化などの負の相互作用を生じ易い。しかし、本実施形態に従うコンタクトレンズ用組成物を用いれば、第一の液がホウ酸を含有しており、且つ、コンタクトレンズ用組成物がポリビニルアルコールを含んでいても、コンタクトレンズ用組成物に低分子ポリオール化合物等が含まれていることにより、負の相互作用の発生を抑制できるのである。その結果、析出物等によるユーザーの眼への刺激が防止できると共に、第一の液に含まれるホウ酸の緩衝作用や防腐作用、殺菌作用が阻害されることも防ぐことができる。
And the composition for contact lenses according to this embodiment is suitably used especially for the first liquid composed of boric acid as a buffering agent and an antiseptic / bactericidal agent. That is, when the first liquid containing boric acid is mixed with a contact lens composition containing a polymer polyol compound such as polyvinyl alcohol, negative interactions such as formation of precipitation and gelation are caused. It is likely to occur. However, when the composition for contact lenses according to this embodiment is used, even if the first liquid contains boric acid and the composition for contact lenses contains polyvinyl alcohol, the composition for contact lenses is used. By including a low molecular polyol compound or the like, generation of negative interaction can be suppressed. As a result, it is possible to prevent irritation to the eyes of the user due to precipitates and the like, and it is also possible to prevent the boric acid buffering action, antiseptic action and bactericidal action contained in the first liquid from being inhibited.
ただし、本実施形態で言う負の相互作用は、ホウ酸とポリビニルアルコールとの相互作用を原因とするものに限定されない。即ち、負の相互作用は、第一の液と、コンタクトレンズ用組成物との混合接触の結果生じ得る、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つを含む作用であればよく、特定の物質同士の混合による特定の現象のみに限定されるものではない。
However, the negative interaction referred to in the present embodiment is not limited to that caused by the interaction between boric acid and polyvinyl alcohol. That is, the negative interaction can occur as a result of the mixed contact between the first liquid and the contact lens composition. Precipitate formation, precipitate formation, gelation, viscosity reduction, contact lens surface water wetting It is sufficient that the action includes at least one of the property reductions, and it is not limited to a specific phenomenon due to mixing of specific substances.
なお、第一の液は、何れかの段階でコンタクトレンズと接触される溶液であればよく、第一の液とコンタクトレンズ用組成物とが混合される際には、第一の液がコンタクトレンズと直接に接触していてもよいし、接触していなくてもよい。即ち、第一の液がコンタクトレンズと接触するのは、第一の液とコンタクトレンズ用組成物との混合接触前でもよいし、混合後でもよい。また、第一の液とコンタクトレンズ用組成物が混合接触する具体的な態様も、特に限定されない。例えば第一の液がコンタクトレンズと共に保存容器等に収容された状態で、そこにコンタクトレンズ用組成物が加えられることで、第一の液とコンタクトレンズ用組成物とが混合されて相互に接触するものでもよいし、第一の液にコンタクトレンズが浸漬される前、又は、コンタクトレンズが第一の液から取り出された段階で、第一の液に対してコンタクトレンズ用組成物が混合されてもよい。また、ユーザーの眼にコンタクトレンズが装着された状態で、ユーザーの角膜付近で第一の液とコンタクトレンズ用組成物とが混合接触するものであってもよい。
The first liquid only needs to be a solution that comes into contact with the contact lens at any stage. When the first liquid and the contact lens composition are mixed, the first liquid is contacted. The lens may be in direct contact or may not be in contact. That is, the first liquid may contact the contact lens before or after the first liquid and the contact lens composition are mixed and contacted. Moreover, the specific aspect in which the first liquid and the contact lens composition are mixed and contacted is not particularly limited. For example, in a state where the first liquid is stored in a storage container or the like together with the contact lens, the contact liquid composition is added thereto, so that the first liquid and the contact lens composition are mixed and brought into contact with each other. The contact lens composition may be mixed with the first liquid before the contact lens is immersed in the first liquid or when the contact lens is removed from the first liquid. May be. Alternatively, the first liquid and the contact lens composition may be in contact with each other in the vicinity of the user's cornea while the contact lens is attached to the user's eye.
なお、本実施形態に従うコンタクトレンズ用組成物は、第一の液とコンタクトレンズ用組成物との混合の結果生じ得る、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つの作用を抑制できるものであればよく、これらの各現象のうちの一つの負の相互作用のみを抑制するものであってもよいし、二つ以上の負の相互作用を何れも抑制できるものでもよい。
In addition, the composition for contact lenses according to the present embodiment can be generated as a result of mixing the first liquid and the composition for contact lenses, formation of precipitates, formation of precipitates, gelation, decrease in viscosity, contact lens surface As long as it can suppress at least one action of reducing the wettability of water, only one negative interaction among these phenomena may be suppressed, or two or more It may be one that can suppress any negative interaction.
また、負の相互作用を抑制する方法に関する本発明の第一の実施形態は、上述のコンタクトレンズ用組成物に関する本発明の一実施形態に従うコンタクトレンズ用組成物を用いることにより、好適に実施される。先ず、コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液としては、上述のコンタクトレンズ用組成物に関する本発明の一実施形態に従う第一の液を採用することが望ましい。そして、このような第一の液に対して、上述のコンタクトレンズ用組成物に関する本発明の一実施形態に従うコンタクトレンズ用組成物を、混合接触する。これにより、第一の液とコンタクトレンズ用組成物との混合により発生する、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つを含む負の相互作用を抑制することができる。
In addition, the first embodiment of the present invention relating to a method for suppressing negative interaction is suitably implemented by using the contact lens composition according to one embodiment of the present invention relating to the above-described contact lens composition. The First, at least one of contact lens multipurpose liquid, bactericidal liquid, cleaning liquid, protein cleaning / removing agent, preservative liquid, rinsing liquid, eye drops, eyewash liquid, mounting liquid, packaging solution, hydration liquid, and tear liquid As the first liquid that contacts the contact lens selected from the above, it is desirable to employ the first liquid according to one embodiment of the present invention relating to the above-described composition for contact lenses. And the composition for contact lenses according to one Embodiment of this invention regarding the composition for contact lenses mentioned above is mixed-contacted with such a 1st liquid. As a result, at least one of precipitation generation, precipitate generation, gelation, viscosity reduction, and water wettability reduction of the contact lens surface generated by mixing the first liquid and the contact lens composition. Negative interaction including can be suppressed.
一方、負の相互作用を抑制する方法に関する第二の実施形態としては、上述の負の相互作用を抑制する方法に関する第一の実施形態において、特にグルコース、スクロース、ラクトース、マルトース、トレハロース、エリトリトール、キシリトール、マルチトール、マンニトール、ソルビトールからなる低分子ポリオール化合物から選択された少なくとも一つを含むコンタクトレンズ用組成物を採用することにより、第一の液との負の相互作用を好適に抑制することができる。
On the other hand, as a second embodiment relating to a method for suppressing negative interaction, in the first embodiment relating to the method for suppressing negative interaction described above, in particular, glucose, sucrose, lactose, maltose, trehalose, erythritol, Adopting a composition for contact lenses containing at least one selected from low molecular polyol compounds consisting of xylitol, maltitol, mannitol, sorbitol, to suitably suppress negative interaction with the first liquid Can do.
以上、コンタクトレンズ用組成物に関する本発明、及び、負の相互作用を抑制する方法に関する本発明の好適な実施態様を具体的に例示しつつ、各発明について詳述してきたが、これはあくまでも例示であって、これらの本発明は、上述の具体的な記載によって、何等、限定的に解釈されるものではない。
The present invention relating to the composition for contact lenses and the preferred embodiment of the present invention relating to the method for suppressing negative interaction have been described in detail while specifically illustrating preferred embodiments of the present invention. However, the present invention is not construed as being limited to the above specific description.
以下に、コンタクトレンズ用組成物に関する本発明、及び、負の相互作用を抑制する方法に関する本発明について、その技術的意義を一層明確にするため行った実験結果を示す。
Hereinafter, the results of experiments conducted to further clarify the technical significance of the present invention relating to the composition for contact lenses and the present invention relating to a method for suppressing negative interactions will be described.
(実験例1)
先ず、第一の液として市販のコンタクトレンズ用多目的液剤を用いて、本実施形態に従うコンタクトレンズ用組成物と混合し、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 1)
First, using a commercially available multipurpose liquid for contact lenses as the first liquid, an experiment for confirming the inhibitory effect of negative interaction was performed by mixing with the composition for contact lenses according to the present embodiment.
先ず、第一の液として市販のコンタクトレンズ用多目的液剤を用いて、本実施形態に従うコンタクトレンズ用組成物と混合し、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 1)
First, using a commercially available multipurpose liquid for contact lenses as the first liquid, an experiment for confirming the inhibitory effect of negative interaction was performed by mixing with the composition for contact lenses according to the present embodiment.
第一の液としては、市販のコンタクトレンズ用多目的液剤であるバイオクレンゼロ(株式会社オフテクス製)を採用した。なお、このバイオクレンゼロは、塩酸ポリヘキサニド(殺菌剤)製剤を1mlに0.001mg含有しており、その他に、安定剤、緩衝剤、等張化剤、pH調整剤、界面活性剤、ポリリジン、ヒプロメロース、ヒアルロン酸ナトリウム、ホウ酸、ポリオキシエチレンポリオキシプロピレングリコールを含んでいる。一方、本実験に用いたコンタクトレンズ用組成物の組成は、以下の表1に示すとおりである。即ち、実施例1~10は、低分子ポリオール化合物として、マンニトール、ソルビトール、グルコース、トレハロース、エリトリトールのうちの何れかを含んでいる。これに対し、比較例1,2は、これら低分子ポリオール化合物を含んでいない。これら実施例1~10及び比較例1,2のコンタクトレンズ用組成物と、第一の液とを、それぞれ容量比1:1の割合で混合した。混合後、沈殿や析出物が生じたものを×、沈殿や析出物は生じないが、溶液全体が白濁したものを△、沈殿及び析出の生成や白濁化が何れも観察されなかったものを○と評価した。その結果を以下の表1に併せて示す。
As the first liquid, Bioclen Zero (manufactured by Offtex Co., Ltd.), which is a commercially available multipurpose liquid for contact lenses, was employed. In addition, this bioclen zero contains 0.001 mg of polyhexanide hydrochloride (bactericidal agent) preparation in 1 ml. In addition, a stabilizer, a buffer, an isotonic agent, a pH adjuster, a surfactant, polylysine, Contains hypromellose, sodium hyaluronate, boric acid, polyoxyethylene polyoxypropylene glycol. On the other hand, the composition of the contact lens composition used in this experiment is as shown in Table 1 below. That is, Examples 1 to 10 contain any one of mannitol, sorbitol, glucose, trehalose, and erythritol as a low molecular polyol compound. On the other hand, Comparative Examples 1 and 2 do not contain these low molecular polyol compounds. The contact lens compositions of Examples 1 to 10 and Comparative Examples 1 and 2 and the first liquid were mixed at a volume ratio of 1: 1. After mixing, x indicates that precipitation or precipitation occurred, no precipitation or precipitation occurs, but Δ indicates that the entire solution is cloudy, and ○ indicates that neither precipitation nor precipitation or clouding was observed. It was evaluated. The results are also shown in Table 1 below.
表1に示す結果からも明らかなように、低分子ポリオール化合物を含まないコンタクトレンズ用組成物を用いた比較例1及び2では、何れも評価が×となっており、低分子ポリオール化合物を含まないコンタクトレンズ用組成物と各第一の液との混合によって、負の相互作用としての沈殿や析出物の生成が生じていることがわかる。一方、低分子ポリオール化合物を含むコンタクトレンズ用組成物を用いた実施例1~10では、析出物の評価が何れも○又は△となっており、負の相互作用としての沈殿や析出物の生成が抑制されている。
As is clear from the results shown in Table 1, in Comparative Examples 1 and 2 using the composition for contact lenses that does not contain the low molecular polyol compound, the evaluation is x, and the low molecular polyol compound is included. It can be seen that the mixture of the first contact lens composition and the first liquid causes precipitation or precipitate formation as a negative interaction. On the other hand, in Examples 1 to 10 using the contact lens composition containing the low-molecular polyol compound, the evaluation of the precipitates is all “◯” or “Δ”, and precipitation and precipitate generation as a negative interaction Is suppressed.
なお、本実験では、高分子ポリオール化合物として、4重量%水溶液としたときの動粘度が約5mm2 /sであるポリビニルアルコールと、4重量%水溶液としたときの動粘度が約24mm2 /sであるポリビニルアルコールの二種類を使用している。これら4重量%水溶液としたときの動粘度が約30mm2 /s以下の二種類のうち何れのポリビニルアルコールを使用した場合にも、負の相互作用を良好に抑制し得ている。なお、各ポリビニルアルコールの動粘度の値はメーカーの規格値であり、医薬品添加物規格により定められたポリビニルアルコール(部分けん化)の粘度測定法に従い測定されたものである。即ち、4重量%水溶液をウベローデ粘度計を使用して、20℃で測定された数値である。
In this experiment, as the polymer polyol compound, polyvinyl alcohol having a kinematic viscosity of about 5 mm 2 / s when a 4% by weight aqueous solution is used and about 24 mm 2 / s when a 4% by weight aqueous solution is used. Two types of polyvinyl alcohol are used. The negative interaction can be satisfactorily suppressed even when any of the two types of polyvinyl alcohols having a kinematic viscosity of about 30 mm 2 / s or less when used as a 4% by weight aqueous solution is used. In addition, the value of kinematic viscosity of each polyvinyl alcohol is a manufacturer's standard value, and is measured in accordance with the viscosity measurement method of polyvinyl alcohol (partial saponification) defined by the pharmaceutical additive standard. That is, it is a numerical value measured at 20 ° C. using a Ubbelohde viscometer with a 4 wt% aqueous solution.
なお、上述のとおり、市販のコンタクトレンズ用多目的液剤であるバイオクレンゼロにはホウ酸が配合されており、比較例1,2で見られた析出や沈殿の生成等の負の相互作用は、ホウ酸とポリビニルアルコールとの混合接触が主な要因であることが推察される。そして、実施例1~10では、マンニトール等の低分子ポリオール化合物を配合することで、ホウ酸を含む第一の液とポリビニルアルコールを含むコンタクトレンズ用組成物とを混合しても、負の相互作用の発生を有効に抑制できていることがわかる。
In addition, as described above, boric acid is blended in bioclen zero, which is a commercially available multipurpose liquid for contact lenses, and negative interactions such as precipitation and precipitation seen in Comparative Examples 1 and 2, It is presumed that the mixed contact between boric acid and polyvinyl alcohol is the main factor. In Examples 1 to 10, even when the first liquid containing boric acid and the composition for contact lenses containing polyvinyl alcohol were mixed with a low molecular polyol compound such as mannitol, negative mutual It turns out that generation | occurrence | production of an effect | action can be suppressed effectively.
(実験例2)
次に、上述の実験例1で用いた第一の液に換えて、市販のコンタクトレンズの包装溶液、及び、コンタクトレンズ用の点眼液(人工涙液)を用いて、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 2)
Next, in place of the first solution used in Experimental Example 1 described above, a negative contact interaction is suppressed by using a commercially available contact lens packaging solution and contact lens ophthalmic solution (artificial tear). An experiment was conducted to confirm the effect.
次に、上述の実験例1で用いた第一の液に換えて、市販のコンタクトレンズの包装溶液、及び、コンタクトレンズ用の点眼液(人工涙液)を用いて、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 2)
Next, in place of the first solution used in Experimental Example 1 described above, a negative contact interaction is suppressed by using a commercially available contact lens packaging solution and contact lens ophthalmic solution (artificial tear). An experiment was conducted to confirm the effect.
使用した第一の液は、以下の表2に示すとおりである。即ち、コンタクトレンズの包装溶液の例として、市販の1日使い捨て用ソフトコンタクトレンズであるワンデーアキュビュー(ジョンソン・エンド・ジョンソン株式会社製)のパッケージ内に封入されている包装溶液を採用した。なお、ワンデーアキュビューの包装溶液には、塩化ナトリウム、緩衝剤が配合されている。この緩衝剤の物質名、及び、その他の組成配合の詳細は不明であるが、発明者らが分析を行った結果、この包装溶液にはホウ酸が配合されていることが判明している。よって、緩衝剤として、ホウ酸系緩衝剤が使用されていることが推察される。また、市販のコンタクトレンズ用の点眼液(人工涙液)の例として、ロートCキューブクールチャージα(ロート製薬株式会社製)を採用した。このロートCキューブクールチャージαには、塩化カリウム0.080%、塩化ナトリウム0.440%、ヒドロキシエチルセルロース0.070%が配合されており、その他の添加物として、ホウ酸、ホウ砂、ポリオキシエチレンポリオキシプロピレングリコール、ポリオキシエチレン硬化ヒマシ油、エデト酸Na、1-メントール、pH調節剤が配合されている。コンタクトレンズ用組成物としては、表2に示すとおり、上述の実験例1で用いた実施例8及び比較例2と同一のものを用いた。これら第一の液とコンタクトレンズ用組成物とを、それぞれ容量比1:1の割合で混合した。混合後、沈殿や析出物が生じたものを×、沈殿や析出物は生じないが、溶液全体が白濁したものを△、沈殿及び析出の生成や白濁化が何れも観察されなかったものを○と評価した。その評価結果を以下の表2に併せて示す。
The first liquid used is as shown in Table 2 below. That is, as an example of a contact lens packaging solution, a packaging solution enclosed in a package of One Day Accuview (manufactured by Johnson & Johnson Co., Ltd.), a commercially available daily disposable soft contact lens, was employed. In addition, sodium chloride and a buffer agent are mix | blended with the packaging solution of 1 day accu-view. Although the substance name of this buffering agent and other details of composition are unknown, the inventors have analyzed and found that boric acid is blended in this packaging solution. Therefore, it is guessed that the boric acid type buffering agent is used as a buffering agent. Moreover, Rohto C Cube Cool Charge α (manufactured by Rohto Pharmaceutical Co., Ltd.) was employed as an example of commercially available eye drops (artificial tears) for contact lenses. This funnel C cube cool charge α contains 0.080% potassium chloride, 0.440% sodium chloride and 0.070% hydroxyethyl cellulose. Other additives include boric acid, borax, polyoxy Ethylene polyoxypropylene glycol, polyoxyethylene hydrogenated castor oil, Na edetate, 1-menthol, and pH regulator are blended. As the composition for contact lenses, as shown in Table 2, the same compositions as in Example 8 and Comparative Example 2 used in Experimental Example 1 were used. These first liquid and contact lens composition were mixed at a volume ratio of 1: 1. After mixing, x indicates that precipitation or precipitation occurred, no precipitation or precipitation occurs, but Δ indicates that the whole solution is cloudy, and ○ indicates that neither precipitation nor precipitation or clouding was observed. It was evaluated. The evaluation results are also shown in Table 2 below.
表2に示す結果からも明らかなように、低分子ポリオール化合物を含まないコンタクトレンズ用組成物を用いた比較例2では、二種類の第一の液の何れでも評価が×となっており、低分子ポリオール化合物を含まないコンタクトレンズ用組成物と各第一の液との相互作用によって、沈殿及び析出物の生成等の負の相互作用が生じることがわかる。一方、低分子ポリオール化合物としてマンニトールを含むコンタクトレンズ用組成物を用いた実施例8では、評価が何れも○となっており、沈殿や析出物の生成といった負の相互作用が有効に抑えられている。
As is clear from the results shown in Table 2, in Comparative Example 2 using the composition for contact lenses that does not contain a low-molecular polyol compound, the evaluation of any of the two types of the first liquid is x. It can be seen that the interaction between the contact lens composition containing no low molecular polyol compound and each first liquid causes a negative interaction such as precipitation and formation of a precipitate. On the other hand, in Example 8 using the composition for contact lenses containing mannitol as the low-molecular polyol compound, the evaluations are all good, and negative interactions such as the formation of precipitates and precipitates are effectively suppressed. Yes.
この結果から、コンタクトレンズ用組成物に低分子ポリオール化合物を配合することで、第一の液がコンタクトレンズ用の包装溶液、及び、コンタクトレンズ用の点眼液(人工涙液)であっても、負の相互作用である沈殿及び析出物の生成が抑制されることが確認できる。なお、本実験で用いた市販のコンタクトレンズの包装溶液、及び、コンタクトレンズ用の点眼液には、何れもホウ酸が配合されており、負の相互作用の主な要因がホウ酸とポリビニルアルコールとの混合接触であることが推測される。
From this result, by blending the low molecular polyol compound in the composition for contact lenses, even if the first liquid is a packaging solution for contact lenses, and eye drops (artificial tears) for contact lenses, It can be confirmed that the generation of precipitates and precipitates, which are negative interactions, is suppressed. Both the commercially available contact lens packaging solution used in this experiment and the ophthalmic solution for contact lenses contain boric acid, and the main factors of negative interaction are boric acid and polyvinyl alcohol. It is presumed that this is a mixed contact.
(実験例3)
更に、第一の液として市販のコンタクトレンズ用多目的液剤又は洗眼液を用い、且つ、動粘度の異なるポリビニルアルコールを用いたコンタクトレンズ用組成物における、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 3)
Furthermore, an experiment to confirm the negative interaction suppression effect in a contact lens composition using a commercially available contact lens multipurpose liquid or eyewash as the first liquid and polyvinyl alcohol having a different kinematic viscosity. went.
更に、第一の液として市販のコンタクトレンズ用多目的液剤又は洗眼液を用い、且つ、動粘度の異なるポリビニルアルコールを用いたコンタクトレンズ用組成物における、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 3)
Furthermore, an experiment to confirm the negative interaction suppression effect in a contact lens composition using a commercially available contact lens multipurpose liquid or eyewash as the first liquid and polyvinyl alcohol having a different kinematic viscosity. went.
使用した第一の液及びコンタクトレンズ用組成物の詳細は、以下の表3に示すとおりである。即ち、第一の液としてのコンタクトレンズ用多目的液剤は、上述の実験例1と同じくバイオクレンゼロ(株式会社オフテクス製)を採用し、洗眼液としては、市販の洗眼液であるアイボン(小林製薬株式会社製)を採用した。バイオクレンゼロの組成は既に述べたためここでの記載は省略する。一方、洗眼液であるアイボンには、イプシロンアミノカプロン酸0.2%、グリチルリチン酸二カリウム0.01%、マレイン酸クロルフェニラミン0.003%、ピリドキシン塩酸塩(ビタミンB6)0.01%、トコフェロール酢酸エステル0.005%、コンドロイチン硫酸ナトリウム0.04%が配合されており、その他の添加物としては、ホウ酸、ホウ砂、エデト酸ナトリウム水和物、ポリソルべート80、l-メントール、d-ボルネオール、pH調整剤が配合されている。即ち、これらの多目的液剤及び洗眼液には、何れもホウ酸が含まれている。また、コンタクトレンズ用組成物に含まれるポリビニルアルコールは、4重量%水溶液における動粘度がそれぞれ25mm2 /s,40mm2 /sである二種類を採用した。実施例11~16には低分子ポリオール化合物としてマンニトール又はエリトリトールの何れかが配合されている。これらの第一の液と各コンタクトレンズ用組成物とを、それぞれ容量比1:1の割合で混合した。その結果、沈殿や析出物が生じたものを×、沈殿や析出物は生じないが、溶液全体が白濁したものを△、沈殿及び析出の生成や白濁化が何れも観察されなかったものを○と評価した。その評価結果を以下の表3に併せて示す。
The details of the first liquid and the contact lens composition used are as shown in Table 3 below. That is, the multipurpose liquid for contact lenses as the first liquid employs Bioclen Zero (manufactured by Off-Tex Co., Ltd.) in the same manner as in Experimental Example 1 described above, and as the eyewash, Ivon (Kobayashi Pharmaceutical Co., Ltd.) is a commercially available eyewash. Adopted). Since the composition of bioclen zero has already been described, description thereof is omitted here. On the other hand, Ivon, an eyewash, contains 0.2% epsilon aminocaproic acid, 0.01% dipotassium glycyrrhizinate, 0.003% chlorpheniramine maleate, 0.01% pyridoxine hydrochloride (vitamin B6), tocopherol 0.005% acetate ester and 0.04% sodium chondroitin sulfate are blended. Other additives include boric acid, borax, sodium edetate hydrate, polysorbate 80, l-menthol, d-Borneol and pH adjuster are blended. That is, both of these multipurpose liquids and eyewashes contain boric acid. Further, polyvinyl alcohol contained in the contact lens composition has a kinematic viscosity at 4 wt% aqueous solution, respectively 25 mm 2 / s, two types is 40 mm 2 / s is adopted. Examples 11 to 16 contain either mannitol or erythritol as a low molecular polyol compound. These first liquid and each contact lens composition were mixed at a volume ratio of 1: 1. As a result, the precipitate or precipitate produced x, no precipitate or precipitate was produced, but the whole solution became cloudy Δ, no precipitate or precipitate formation or clouding was observed ○ It was evaluated. The evaluation results are also shown in Table 3 below.
表3に示す結果からも明らかなように、低分子ポリオール化合物を含まないコンタクトレンズ用組成物を用いた比較例3,4では、二種類の第一の液の何れでも評価が×となっており、低分子ポリオール化合物を含まないコンタクトレンズ用組成物と各第一の液との相互作用によって、負の相互作用としての沈殿及び析出物の生成が生じることがわかる。一方、低分子ポリオール化合物としてマンニトール又はエリトリトールを含むコンタクトレンズ用組成物を用いた実施例11~16では、析出物の評価が何れも○又は△となっており、負の相互作用である沈殿や析出物の生成が有効に抑えられている。
As is clear from the results shown in Table 3, in Comparative Examples 3 and 4 using the composition for contact lenses that does not contain the low-molecular polyol compound, the evaluation was x in any of the two types of the first liquid. Thus, it can be seen that the interaction between the contact lens composition not containing the low molecular polyol compound and each first liquid causes precipitation and precipitate formation as negative interactions. On the other hand, in Examples 11 to 16 using the composition for contact lenses containing mannitol or erythritol as the low-molecular polyol compound, the evaluation of the precipitates was either ◯ or △. Formation of precipitates is effectively suppressed.
また、動粘度の異なる二種のポリビニルアルコールを用いた結果を相互に比較すると、4重量%水溶液における動粘度が25mm2 /sのポリビニルアルコールを用いた実施例において、負の相互作用がより確実に抑制されていることが確認できる。よって、本実施形態に用いられる高分子ポリオール化合物としては、4重量%水溶液としたときの動粘度が約30mm2 /s以下ポリビニルアルコールを採用することが望ましいことがわかる。なお、ポリビニルアルコールの濃度が低いほど、負の相互作用は容易に抑制でき、濃度が高くなるほど負の相互作用が生じる傾向にあることも確認できる。
In addition, when the results using two types of polyvinyl alcohols having different kinematic viscosities are compared with each other, in an example using polyvinyl alcohol having a kinematic viscosity of 25 mm 2 / s in a 4% by weight aqueous solution, negative interaction is more reliable. Can be confirmed. Therefore, it can be seen that it is desirable to use polyvinyl alcohol having a kinematic viscosity of about 30 mm 2 / s or less when a 4 wt% aqueous solution is used as the polymer polyol compound used in the present embodiment. In addition, it can also confirm that a negative interaction can be easily suppressed as the concentration of polyvinyl alcohol decreases, and a negative interaction tends to occur as the concentration increases.
(実験例4)
第一の液として、ポリビニルアルコールが配合された市販のコンタクトレンズ用の装着液と、ホウ酸を含むコンタクトレンズ用組成物とを用いて、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 4)
As a first solution, an experiment was conducted to confirm the negative interaction suppression effect using a commercially available contact lens mounting solution containing polyvinyl alcohol and a contact lens composition containing boric acid. .
第一の液として、ポリビニルアルコールが配合された市販のコンタクトレンズ用の装着液と、ホウ酸を含むコンタクトレンズ用組成物とを用いて、負の相互作用の抑制効果を確認する実験を行った。 (Experimental example 4)
As a first solution, an experiment was conducted to confirm the negative interaction suppression effect using a commercially available contact lens mounting solution containing polyvinyl alcohol and a contact lens composition containing boric acid. .
使用した第一の液及びコンタクトレンズ用組成物の詳細は、以下の表4に示すとおりである。即ち、第一の液としてのコンタクトレンズ用の装着液としては、市販の装着液であるスマイルコンタクトファインフィット(ライオン株式会社製)を採用した。なお、スマイルコンタクトファインフィットには、ヒドロキシルプロピルメチルセルロース2910 1.0%、L-アスパラギン酸カリウム0.1%、アミノエチルスルホン酸1.0%、塩化ナトリウム0.6%、ポリビニルアルコール(部分けん化物)2.0%が含まれており、その他の添加物としては、エデト酸Na、シクロデキストリン、塩化ベンザルコニウム、pH調整剤が含まれている。即ち、この装着液にはポリビニルアルコールが含まれる一方、ホウ酸は含まれていない。また、コンタクトレンズ用組成物は、実施例及び比較例の何れもホウ酸を含む一方、ポリビニルアルコールを含まない組成とした。更に、実施例17には低分子ポリオール化合物としてマンニトールを配合した。これらの第一の液とコンタクトレンズ用組成物とを、それぞれ容量比1:1の割合で混合し、沈殿や析出物が生じたものを×、沈殿や析出物は生じないが、溶液全体が白濁したものを△、沈殿及び析出の生成や白濁化が何れも観察されなかったものを○と評価した。その結果を以下の表4に示す。
Details of the first liquid and the contact lens composition used are as shown in Table 4 below. That is, Smile Contact Fine Fit (manufactured by Lion Corporation), which is a commercially available mounting liquid, was employed as the mounting liquid for contact lenses as the first liquid. For Smile Contact Finefit, hydroxylpropyl methylcellulose 2910 1.0%, potassium L-aspartate 0.1%, aminoethylsulfonic acid 1.0%, sodium chloride 0.6%, polyvinyl alcohol (partially saponified product) ) 2.0%, and other additives include Na edetate, cyclodextrin, benzalkonium chloride, and a pH adjuster. That is, this mounting solution contains polyvinyl alcohol but does not contain boric acid. Moreover, the composition for contact lenses was made into the composition which does not contain polyvinyl alcohol, while both an Example and a comparative example contain boric acid. Furthermore, in Example 17, mannitol was blended as a low molecular polyol compound. These first liquid and contact lens composition were mixed at a volume ratio of 1: 1, respectively, and x and a precipitate or precipitate were produced. The white turbid one was evaluated as Δ, and the one in which neither precipitation nor precipitation generation nor white turbidity was observed was evaluated as ◯. The results are shown in Table 4 below.
表4に示す結果からも明らかなように、低分子ポリオール化合物を含まないコンタクトレンズ用組成物を用いた比較例5では、評価が×となっており、ポリビニルアルコールを含む第一の液と、ホウ酸を含むコンタクトレンズ用組成物との混合によって、負の相互作用である沈殿析出物の生成が起きることがわかる。一方、低分子ポリオール化合物としてマンニトールを含むコンタクトレンズ用組成物を用いた実施例17では、評価は○となっており、比較例5で発生していた負の相互作用が有効に抑えられている。即ち、第一の液がポリビニルアルコールを含み、且つ、コンタクトレンズ用組成物がホウ酸を含む場合であっても、コンタクトレンズ用組成物が低分子ポリオール化合物を含むことにより、負の相互作用を抑制できることが確認できる。
As is clear from the results shown in Table 4, in Comparative Example 5 using the composition for contact lenses that does not contain a low molecular polyol compound, the evaluation is x, and the first liquid containing polyvinyl alcohol, It can be seen that mixing with a composition for contact lenses containing boric acid results in the formation of a precipitate that is a negative interaction. On the other hand, in Example 17 using the composition for contact lenses containing mannitol as the low-molecular-weight polyol compound, the evaluation is ○, and the negative interaction generated in Comparative Example 5 is effectively suppressed. . That is, even when the first liquid contains polyvinyl alcohol and the contact lens composition contains boric acid, the contact lens composition contains a low-molecular polyol compound, thereby causing a negative interaction. It can be confirmed that it can be suppressed.
(実験例5)
第一の液として市販のコンタクトレンズ用多目的液剤を用いて、動粘度の異なるポリビニルアルコールを用いたコンタクトレンズ用組成物と混合し、その動粘度を確認する実験を行った。 (Experimental example 5)
Using a commercially available multi-purpose liquid for contact lenses as a first liquid, an experiment was conducted in which the kinematic viscosity was confirmed by mixing with a composition for contact lenses using polyvinyl alcohol having different kinematic viscosities.
第一の液として市販のコンタクトレンズ用多目的液剤を用いて、動粘度の異なるポリビニルアルコールを用いたコンタクトレンズ用組成物と混合し、その動粘度を確認する実験を行った。 (Experimental example 5)
Using a commercially available multi-purpose liquid for contact lenses as a first liquid, an experiment was conducted in which the kinematic viscosity was confirmed by mixing with a composition for contact lenses using polyvinyl alcohol having different kinematic viscosities.
使用した第一の液及びコンタクトレンズ用組成物の詳細は、以下の表5に示すとおりである。即ち、第一の液としてのコンタクトレンズ用多目的液剤としては、市販の多目的液剤であるバイオクレンゼロ(株式会社オフテクス製)を採用した。また、コンタクトレンズ用組成物に含まれるポリビニルアルコールは、4重量%水溶液における動粘度がそれぞれ5mm2 /s,25mm2 /s,40mm2 /sである三種類を採用した。第一の液と、これらのコンタクトレンズ用組成物とを、それぞれ容量比1:1の割合で混合した。そして、混合後の溶液の20℃での動粘度を、ウベローデ粘度計(柴田科学株式会社製)を用いて測定した。
The details of the first liquid and the contact lens composition used are as shown in Table 5 below. That is, as the first-purpose multi-purpose liquid for contact lenses, Bioclen Zero (manufactured by Offtex Co., Ltd.), which is a commercially available multi-purpose liquid, was employed. Further, polyvinyl alcohol contained in the contact lens composition has a kinematic viscosity at 4 wt% aqueous solution was 5 mm 2 / s, respectively, 25 mm 2 / s, the three is 40 mm 2 / s is adopted. The first liquid and these contact lens compositions were mixed at a volume ratio of 1: 1. And the kinematic viscosity at 20 degreeC of the solution after mixing was measured using the Ubbelohde viscometer (made by Shibata Kagaku Co., Ltd.).
表5に示す結果からも明らかなように、低分子ポリオール化合物が配合された実施例18~21と、低分子ポリオール化合物が配合されていない比較例6~8とを比較すると、4重量%水溶液における動粘度が5mm2 /s,25mm2 /s,40mm2 /sのポリビニルアルコールを用いた何れの実施例においても、同じポリビニルアルコールを用いた比較例よりも動粘度が高くなっている。即ち、比較例6~8では負の相互作用としての粘度の低下が生じている一方、実施例18~21では粘度の低下が抑えられ、動粘度を高い数値で維持できていることがわかる。即ち、これらの実施例18~21では、低分子ポリオール化合物を配合することによって、負の相互作用としての粘度の低下を抑制できていることが確認できる。
As is apparent from the results shown in Table 5, when Examples 18 to 21 in which the low molecular polyol compound was blended with Comparative Examples 6 to 8 in which the low molecular polyol compound was not blended, a 4% by weight aqueous solution kinematic viscosity 5mm 2 / s, 25mm 2 / s, in either embodiment using a polyvinyl alcohol 40 mm 2 / s, kinematic viscosity is higher than comparative example using the same polyvinyl alcohol in. That is, in Comparative Examples 6 to 8, the viscosity decrease as a negative interaction occurs, while in Examples 18 to 21, the decrease in viscosity is suppressed and the kinematic viscosity can be maintained at a high value. That is, in Examples 18 to 21, it can be confirmed that the low molecular polyol compound is compounded to suppress a decrease in viscosity as a negative interaction.
一方、動粘度の異なるポリビニルアルコールを用いた結果を相互に比較すると、4重量%水溶液における動粘度が5mm2 /s,25mm2 /sのポリビニルアルコールを用いた実施例18~20において、動粘度の値が特に高くなっており、粘度の低下を特に良好に抑制できていることがわかる。従って、負の相互作用である粘度の低下を抑制するには、特に、4重量%水溶液における動粘度が30mm2 /s以下のポリビニルアルコールを用いることが望ましいことが確認できる。なお、動粘度が30mm2 /sよりも大きなポリビニルアルコールであっても、析出の生成に対する抑制効果は充分に発揮できることは、先の実験例3(実施例14~16)で確認したとおりである。
On the other hand, when comparing the results with different polyvinylalcohol having a kinematic viscosity from each other, the kinematic viscosity at 4 wt% aqueous solution 5 mm 2 / s, Examples 18 to 20 using the polyvinyl alcohol 25 mm 2 / s, kinematic viscosity This value is particularly high, and it can be seen that the decrease in viscosity can be suppressed particularly well. Therefore, it can be confirmed that it is particularly desirable to use polyvinyl alcohol having a kinematic viscosity of 30 mm 2 / s or less in a 4% by weight aqueous solution in order to suppress a decrease in viscosity, which is a negative interaction. It should be noted that, as confirmed in Experimental Example 3 (Examples 14 to 16), even if the polyvinyl alcohol has a kinematic viscosity greater than 30 mm 2 / s, the effect of suppressing the formation of precipitation can be sufficiently exerted. .
(実験例6)
第一の液として市販のコンタクトレンズ用多目的液剤を用いて、本実施形態に従うコンタクトレンズ用組成物と混合し、濡れ性の向上効果を確認する実験を行った。 (Experimental example 6)
Using a commercially available multipurpose liquid for contact lenses as the first liquid, it was mixed with the composition for contact lenses according to the present embodiment, and an experiment for confirming the effect of improving wettability was conducted.
第一の液として市販のコンタクトレンズ用多目的液剤を用いて、本実施形態に従うコンタクトレンズ用組成物と混合し、濡れ性の向上効果を確認する実験を行った。 (Experimental example 6)
Using a commercially available multipurpose liquid for contact lenses as the first liquid, it was mixed with the composition for contact lenses according to the present embodiment, and an experiment for confirming the effect of improving wettability was conducted.
第一の液としては市販のコンタクトレンズ用多目的液剤であるバイオクレンゼロ(株式会社オフテクス製)を採用し、これを以下の表6に示す組成のコンタクトレンズ用組成物と、容量比1:1の割合で混合した。この混合溶液に試験レンズ(株式会社メニコン製、メニコン2ウィークプレミオ)を4時間浸漬した後、レンズを取り出し、レンズ表面に付着した液を軽く拭き取った。その後、生理食塩液をレンズフロントカーブ面に滴下し、レンズ表面の生理食塩液に対する接触角を測定した。そして、実測した各試料の接触角について、比較例10において2回測定を行った平均値を対照基準値として、以下の計算式により濡れ性向上率を算出し、表6に示した。なお、表6に示されるように、比較例10はポリビニルアルコールを含んでおらず、バイオクレンゼロに含まれるホウ酸との混合による負の相互作用が生じないようにされている。また、接触角が小さいほど濡れ性が大きいため、得られた濡れ性向上率が正の場合は、対照である比較例10を用いた場合よりも濡れ性が高いことを意味する。
濡れ性向上率(%)={1-(接触角の実測値)/ (比較例10における平均接触角)}×100 As the first liquid, Bioclen Zero (manufactured by Offtex Co., Ltd.), which is a commercially available multipurpose liquid for contact lenses, is employed, which is a contact lens composition having the composition shown in Table 6 below and a volume ratio of 1: 1. The ratio was mixed. After immersing a test lens (Menicon Co., Ltd., Menicon 2 Week Premio) for 4 hours in this mixed solution, the lens was taken out and the liquid adhering to the lens surface was gently wiped off. Thereafter, physiological saline was dropped on the lens front curve surface, and the contact angle of the lens surface with respect to the physiological saline was measured. Then, with respect to the contact angles of the actually measured samples, the average value obtained by measuring twice in Comparative Example 10 was used as a reference value, and the wettability improvement rate was calculated by the following calculation formula. In addition, as Table 6 shows, the comparative example 10 does not contain polyvinyl alcohol, and it is set as the negative interaction by mixing with the boric acid contained in bioclen zero does not arise. Moreover, since the wettability increases as the contact angle decreases, when the obtained wettability improvement rate is positive, it means that the wettability is higher than when the comparative example 10 as a control is used.
Wettability improvement rate (%) = {1− (actual value of contact angle) / (average contact angle in Comparative Example 10)} × 100
濡れ性向上率(%)={1-(接触角の実測値)/ (比較例10における平均接触角)}×100 As the first liquid, Bioclen Zero (manufactured by Offtex Co., Ltd.), which is a commercially available multipurpose liquid for contact lenses, is employed, which is a contact lens composition having the composition shown in Table 6 below and a volume ratio of 1: 1. The ratio was mixed. After immersing a test lens (Menicon Co., Ltd., Menicon 2 Week Premio) for 4 hours in this mixed solution, the lens was taken out and the liquid adhering to the lens surface was gently wiped off. Thereafter, physiological saline was dropped on the lens front curve surface, and the contact angle of the lens surface with respect to the physiological saline was measured. Then, with respect to the contact angles of the actually measured samples, the average value obtained by measuring twice in Comparative Example 10 was used as a reference value, and the wettability improvement rate was calculated by the following calculation formula. In addition, as Table 6 shows, the comparative example 10 does not contain polyvinyl alcohol, and it is set as the negative interaction by mixing with the boric acid contained in bioclen zero does not arise. Moreover, since the wettability increases as the contact angle decreases, when the obtained wettability improvement rate is positive, it means that the wettability is higher than when the comparative example 10 as a control is used.
Wettability improvement rate (%) = {1− (actual value of contact angle) / (average contact angle in Comparative Example 10)} × 100
表6に示す結果からも明らかなように、ポリビニルアルコールを含む一方、低分子ポリオール化合物を含まないコンタクトレンズ用組成物を用いた比較例9では、濡れ性向上率がマイナスとなっており、第一の液とのコンタクトレンズ用組成物との混合によって、負の相互作用である濡れ性の低下が生じていることがわかる。一方、低分子ポリオール化合物としてマンニトール又はエリトリトールのうちの何れかを含むコンタクトレンズ用組成物を用いた実施例22~25では、何れも濡れ性向上率がプラスとなっている。特に、ポリビニルアルコールを含む実施例24,25でも、濡れ性向上率はプラスなっており、濡れ性の低下が抑制されていることがわかる。しかも、これらポリビニルアルコールと低分子ポリオール化合物とが組み合わされて配合された実施例24,25の濡れ性向上率は、低分子ポリオール化合物のみが配合された実施例22,23よりも高くなっている。即ち、実施例24,25では、ポリビニルアルコールと低分子ポリオール化合物とが組み合わされたことによって相乗効果が生じ、ポリビニルアルコールを含まず低分子ポリオール化合物のみを配合した実施例22,23や、ポリビニルアルコールのみを配合した比較例9よりも、濡れ性が飛躍的に改善されているのである。この結果から、本実施形態に従いポリビニルアルコールと低分子ポリオール化合物とを組み合わせて配合したコンタクトレンズ用組成物を用いれば、負の相互作用を良好に抑制できるだけでなく、コンタクトレンズの濡れ性を大きく増強できることがわかる。
As is clear from the results shown in Table 6, in Comparative Example 9 using the composition for contact lenses that contains polyvinyl alcohol but does not contain a low molecular polyol compound, the wettability improvement rate is negative. It can be seen that mixing with the composition for contact lenses with one liquid causes a decrease in wettability, which is a negative interaction. On the other hand, in Examples 22 to 25 using the contact lens composition containing either mannitol or erythritol as the low molecular polyol compound, the wettability improvement rate is positive. In particular, in Examples 24 and 25 containing polyvinyl alcohol, the wettability improvement rate is positive, and it is understood that the decrease in wettability is suppressed. In addition, the wettability improvement rates of Examples 24 and 25 in which these polyvinyl alcohols and low molecular polyol compounds are combined are higher than those in Examples 22 and 23 in which only the low molecular polyol compounds are combined. . That is, in Examples 24 and 25, a synergistic effect was produced by combining polyvinyl alcohol and a low molecular polyol compound, and Examples 22 and 23 in which only a low molecular polyol compound was blended without including polyvinyl alcohol were obtained. The wettability is dramatically improved as compared with Comparative Example 9 in which only No is added. From this result, according to the present embodiment, if a composition for contact lenses containing a combination of polyvinyl alcohol and a low molecular weight polyol compound is used, not only the negative interaction can be suppressed well, but also the wettability of the contact lens is greatly enhanced. I understand that I can do it.
Claims (6)
- コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液に対して、混合接触されるコンタクトレンズ用組成物であって、
前記第一の液との混合接触によって発生する、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つの負の相互作用が抑制されることを特徴とするコンタクトレンズ用組成物。 Select from at least one of contact lens multipurpose solution, bactericidal solution, cleaning solution, protein cleaning / removing agent, preservative solution, rinsing solution, eye drop solution, eye wash solution, mounting solution, packaging solution, hydrating solution, tear solution A contact lens composition that is mixedly contacted with the first liquid that contacts the contact lens,
At least one negative interaction among the generation of precipitates, the formation of precipitates, gelation, reduction in viscosity, and reduction in water wettability of the contact lens surface, which occurs due to mixed contact with the first liquid, is suppressed. A composition for contact lenses. - 低分子ポリオール化合物を含むことを特徴とする請求項1に記載のコンタクトレンズ用組成物。 The contact lens composition according to claim 1, comprising a low-molecular polyol compound.
- 前記低分子ポリオール化合物が、グルコース、スクロース、ラクトース、マルトース、トレハロース、エリトリトール、キシリトール、マルチトール、マンニトール、ソルビトールから選択された少なくとも一つを含むことを特徴とする請求項2に記載のコンタクトレンズ用組成物。 The contact lens according to claim 2, wherein the low molecular polyol compound contains at least one selected from glucose, sucrose, lactose, maltose, trehalose, erythritol, xylitol, maltitol, mannitol, and sorbitol. Composition.
- 高分子ポリオール化合物を含むことを特徴とする請求項1~3の何れか一項に記載のコンタクトレンズ用組成物。 The contact lens composition according to any one of claims 1 to 3, further comprising a polymer polyol compound.
- 前記高分子ポリオール化合物が、4重量%水溶液における動粘度が30mm2 /s以下であるポリビニルアルコールであることを特徴とする、請求項4に記載のコンタクトレンズ用組成物。 The composition for a contact lens according to claim 4, wherein the polymer polyol compound is polyvinyl alcohol having a kinematic viscosity of 30 mm 2 / s or less in a 4 wt% aqueous solution.
- コンタクトレンズ用多目的液剤、殺菌液、洗浄液、タンパク質洗浄・除去剤、保存液、すすぎ液、点眼液、洗眼液、装着液、包装溶液、水和処理液、涙液のうちの少なくとも一つから選択されるコンタクトレンズに接触する第一の液に対して、コンタクトレンズ用組成物を混合接触することによって発生する負の相互作用を抑制する方法であって、
前記コンタクトレンズ用組成物として請求項1~5の何れか一項に記載のコンタクトレンズ用組成物を用い、前記第一の液に混合接触することにより、前記負の相互作用として、沈殿の生成、析出物の生成、ゲル化、粘度の低下、コンタクトレンズ表面の水濡れ性低減のうちの少なくとも一つを抑制することを特徴とする、負の相互作用を抑制する方法。 Select from at least one of contact lens multipurpose solution, bactericidal solution, cleaning solution, protein cleaning / removing agent, preservative solution, rinsing solution, eye drop solution, eye wash solution, mounting solution, packaging solution, hydrating solution, tear solution A method of suppressing negative interaction generated by mixing and contacting the contact lens composition with the first liquid that contacts the contact lens,
The contact lens composition according to any one of claims 1 to 5 is used as the contact lens composition, and a precipitate is generated as the negative interaction by mixing and contacting the first liquid. A method for suppressing a negative interaction characterized by suppressing at least one of precipitate formation, gelation, viscosity reduction, and water wettability reduction of a contact lens surface.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2009/006704 WO2011070613A1 (en) | 2009-12-08 | 2009-12-08 | Composition for contact lenses and method for suppressing negative interaction using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2009/006704 WO2011070613A1 (en) | 2009-12-08 | 2009-12-08 | Composition for contact lenses and method for suppressing negative interaction using same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011070613A1 true WO2011070613A1 (en) | 2011-06-16 |
Family
ID=44145187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/006704 WO2011070613A1 (en) | 2009-12-08 | 2009-12-08 | Composition for contact lenses and method for suppressing negative interaction using same |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011070613A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014114124A1 (en) * | 2013-01-23 | 2014-07-31 | 江苏海伦隐形眼镜有限公司 | Corneal contact lens nursing composition containing trehalose quaternary ammonium salt |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09278610A (en) * | 1996-04-16 | 1997-10-28 | Ofutekusu:Kk | Composition for controlling harmful microorganism |
JP2000314856A (en) * | 1999-04-30 | 2000-11-14 | Hoya Health Care Kk | Cleaning agent for contact lens |
JP2003089601A (en) * | 2001-09-17 | 2003-03-28 | Menicon Co Ltd | Germicidal solution |
JP2004269508A (en) * | 2003-02-20 | 2004-09-30 | Lion Corp | Contact lens-removing liquid and method for removing the same |
JP2005187345A (en) * | 2003-12-24 | 2005-07-14 | Lion Corp | Contact lens-mounting liquid |
JP2009175543A (en) * | 2008-01-25 | 2009-08-06 | Menicon Co Ltd | Solution for contact lens, contact lens, and method for preventing adhesion of disinfectant for contact lens |
-
2009
- 2009-12-08 WO PCT/JP2009/006704 patent/WO2011070613A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09278610A (en) * | 1996-04-16 | 1997-10-28 | Ofutekusu:Kk | Composition for controlling harmful microorganism |
JP2000314856A (en) * | 1999-04-30 | 2000-11-14 | Hoya Health Care Kk | Cleaning agent for contact lens |
JP2003089601A (en) * | 2001-09-17 | 2003-03-28 | Menicon Co Ltd | Germicidal solution |
JP2004269508A (en) * | 2003-02-20 | 2004-09-30 | Lion Corp | Contact lens-removing liquid and method for removing the same |
JP2005187345A (en) * | 2003-12-24 | 2005-07-14 | Lion Corp | Contact lens-mounting liquid |
JP2009175543A (en) * | 2008-01-25 | 2009-08-06 | Menicon Co Ltd | Solution for contact lens, contact lens, and method for preventing adhesion of disinfectant for contact lens |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014114124A1 (en) * | 2013-01-23 | 2014-07-31 | 江苏海伦隐形眼镜有限公司 | Corneal contact lens nursing composition containing trehalose quaternary ammonium salt |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5472402B2 (en) | Soft contact lens composition and adsorption suppression method | |
US20060052340A1 (en) | Ophthalmic solution | |
JP6538920B2 (en) | Aqueous solution | |
JP6223890B2 (en) | Ophthalmic composition liquid and method of use thereof | |
JP6582029B2 (en) | Ophthalmic composition liquid and method of use thereof | |
JP4850513B2 (en) | Ophthalmic composition | |
JP4751482B2 (en) | Contact lens solution | |
JP4099624B2 (en) | Composition for soft contact lenses | |
JP5731046B1 (en) | Contact lens composition | |
JPWO2004084877A1 (en) | Ophthalmic composition | |
JP2008209677A (en) | Germicide deactivating liquid agent | |
WO2005123148A1 (en) | Composition for contact lens | |
JP5678530B2 (en) | Ophthalmic composition for soft contact lenses | |
JP5587359B2 (en) | Contact lens composition | |
JP4981181B1 (en) | Contact lens composition | |
WO2011070613A1 (en) | Composition for contact lenses and method for suppressing negative interaction using same | |
JPWO2015041193A1 (en) | Ophthalmic composition for zwitterionic soft contact lenses | |
JP2005008568A (en) | Composition for ophthalmic use | |
JP2005172912A (en) | Wearing method and stock solution of wearing liquid of soft contact lens and soft contact lens kit | |
JP6616137B2 (en) | Contact lens composition | |
JP6401699B2 (en) | Ophthalmic composition for zwitterionic soft contact lenses | |
JP6366583B2 (en) | Ophthalmic composition for zwitterionic soft contact lenses | |
JP2020109121A (en) | Ophthalmic composition for silicone hydrogel contact lens | |
WO2004082673A1 (en) | Liquid ophthalmic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09852010 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09852010 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |